| Year |
Citation |
Score |
| 2023 |
Gupta A, Hughes MD, Cruz JL, Avihingsanon A, Mwelase N, Severe P, Omoz-Oarhe A, Masheto G, Moran L, Benson CA, Chaisson RE, Swindells S. Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37768207 DOI: 10.1093/cid/ciad583 |
0.365 |
|
| 2023 |
Reid M, Agbassi YJP, Arinaminpathy N, Bercasio A, Bhargava A, Bhargava M, Bloom A, Cattamanchi A, Chaisson R, Chin D, Churchyard G, Cox H, Denkinger CM, Ditiu L, Dowdy D, et al. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. Lancet (London, England). PMID 37716363 DOI: 10.1016/S0140-6736(23)01379-X |
0.321 |
|
| 2023 |
Malhotra A, Nonyane BAS, Shirey E, Mulder C, Hippner P, Mulatu F, Ratshinanga A, Mitiku P, Cohn S, Conradie G, Chihota V, Chaisson RE, Churchyard GJ, Golub J, Dowdy D, et al. Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB). Trials. 24: 475. PMID 37491264 DOI: 10.1186/s13063-023-07514-7 |
0.309 |
|
| 2023 |
Ryckman T, Weiser J, Gombe M, Turner K, Soni P, Tarlton D, Mazhidova N, Churchyard G, Chaisson RE, Dowdy DW. Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis. The Lancet. Global Health. 11: e1205-e1216. PMID 37474228 DOI: 10.1016/S2214-109X(23)00251-6 |
0.377 |
|
| 2023 |
Jarrett RT, van der Heijden Y, Shotwell MS, Chihota V, Marzinke MA, Chaisson RE, Dooley KE, Churchyard GJ. High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. Antimicrobial Agents and Chemotherapy. e0129722. PMID 36622148 DOI: 10.1128/aac.01297-22 |
0.606 |
|
| 2022 |
Pettit AC, Phillips PP, Kurbatova E, Vernon A, Nahid P, Dawson R, Dooley KE, Sanne I, Waja Z, Mohapi L, Podany AT, Samaneka W, Savic RM, Johnson JL, Muzanyi G, ... ... Chaisson RE, et al. Rifapentine with and without moxifloxacin for pulmonary tuberculosis in people with HIV (S31/A5349). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36041016 DOI: 10.1093/cid/ciac707 |
0.648 |
|
| 2022 |
Singh P, Moulton LH, Barnes GL, Gupta A, Msandiwa R, Chaisson RE, Martinson NA. Pregnancy in Women with HIV in a Tuberculosis Preventive Therapy Trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 36000934 DOI: 10.1097/QAI.0000000000003078 |
0.405 |
|
| 2021 |
Podany AT, Pham M, Sizemore E, Martinson N, Samaneka W, Mohapi L, Badal-Faesen S, Dawson R, Johnson JL, Mayanja H, Lalloo U, Whitworth WC, Pettit A, Campbell K, Phillips P, ... ... Chaisson RE, et al. Efavirenz pharmacokinetics and HIV-1 viral suppression among patients receiving TB treatment containing daily high-dose rifapentine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34918028 DOI: 10.1093/cid/ciab1037 |
0.672 |
|
| 2021 |
Churchyard G, Cárdenas V, Chihota V, Mngadi K, Sebe M, Brumskine W, Martinson N, Yimer G, Wang SH, Garcia-Basteiro AL, Nguenha D, Masilela L, Waggie Z, van den Hof S, Charalambous S, ... ... Chaisson RE, et al. Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial. Annals of Internal Medicine. PMID 34424730 DOI: 10.7326/M20-7577 |
0.449 |
|
| 2021 |
Chaisson LH, Saraceni V, Cohn S, Cavalcante SC, Chaisson RE, Durovni B, Golub JE. Yield of repeat tuberculin skin testing for people living with HIV in Brazil. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 34334739 DOI: 10.1097/QAI.0000000000002779 |
0.338 |
|
| 2021 |
Machowski EE, Letutu M, Lebina L, Waja Z, Msandiwa R, Milovanovic M, Gordhan BG, Otwombe K, Friedrich SO, Chaisson R, Diacon AH, Kana B, Martinson N. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. Bmc Infectious Diseases. 21: 466. PMID 34022850 DOI: 10.1186/s12879-021-06133-4 |
0.455 |
|
| 2021 |
Dorman SE, Nahid P, Kurbatova EV, Phillips PPJ, Bryant K, Dooley KE, Engle M, Goldberg SV, Phan HTT, Hakim J, Johnson JL, Lourens M, Martinson NA, Muzanyi G, Narunsky K, ... ... Chaisson RE, et al. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. The New England Journal of Medicine. 384: 1705-1718. PMID 33951360 DOI: 10.1056/NEJMoa2033400 |
0.616 |
|
| 2021 |
Adu-Gyamfi C, Savulescu D, Mikhathani L, Otwombe K, Salazar-Austin N, Chaisson R, Martinson N, George J, Suchard M. Plasma kynurenine-to-tryptophan ratio, a highly sensitive blood-based diagnostic tool for Tuberculosis in HIV-infected pregnant women. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33718949 DOI: 10.1093/cid/ciab232 |
0.376 |
|
| 2020 |
Seedat F, James I, Loubser S, Waja Z, Mallal SA, Hoffmann C, Tiemessen CT, Chaisson RE, Martinson NA. Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression. Tuberculosis (Edinburgh, Scotland). 126: 102023. PMID 33249336 DOI: 10.1016/j.tube.2020.102023 |
0.352 |
|
| 2020 |
Shin H, Jo Y, Chaisson RE, Turner K, Churchyard G, Dowdy DW. Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIV. Journal of the International Aids Society. 23: e25629. PMID 33107219 DOI: 10.1002/jia2.25629 |
0.345 |
|
| 2020 |
Ferguson O, Jo Y, Pennington J, Johnson K, Chaisson RE, Churchyard G, Dowdy D. Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda. Journal of the International Aids Society. 23: e25623. PMID 33073520 DOI: 10.1002/jia2.25623 |
0.395 |
|
| 2020 |
Adu-Gyamfi CG, Snyman T, Makhathini L, Otwombe K, Darboe F, Penn-Nicholson A, Fisher M, Savulescu D, Hoffmann C, Chaisson R, Martinson N, Scriba TJ, George JA, Suchard MS. Diagnostic accuracy of plasma kynurenine/tryptophan ratio, measured by enzyme-linked immunosorbent assay, for pulmonary tuberculosis. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 32800860 DOI: 10.1016/J.Ijid.2020.08.028 |
0.379 |
|
| 2020 |
Rickman HM, Cohn S, Lala SG, Waja Z, Salazar-Austin N, Hoffmann J, Dooley KE, Hoffmann CJ, Chaisson RE, Martinson NA. Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV. International Journal of Tuberculosis and Lung Disease. 24: 681-685. PMID 32718400 DOI: 10.5588/Ijtld.19.0500 |
0.688 |
|
| 2020 |
Chaisson RE. Empirical Antituberculosis Therapy in Advanced HIV Disease - Too Much, Too Late. The New England Journal of Medicine. 382: 2459-2460. PMID 32558472 DOI: 10.1056/Nejme2009679 |
0.463 |
|
| 2020 |
Swindells S, Hughes M, Chaisson RE. Trials of Tuberculosis Preventive Therapy in People with HIV Infection. American Journal of Respiratory and Critical Care Medicine. PMID 32282226 DOI: 10.1164/Rccm.202003-0761Le |
0.533 |
|
| 2020 |
Dooley KE, Savic R, Gupte A, Marzinke MA, Zhang N, Edward VA, Wolf L, Sebe M, Likoti M, Fyvie MJ, Shibambo I, Beattie T, Chaisson RE, Churchyard GJ. Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial. The Lancet. Hiv. PMID 32240629 DOI: 10.1016/S2352-3018(20)30032-1 |
0.702 |
|
| 2020 |
Dorjee K, Sadutshang TD, Rana RS, Topgyal S, Phunkyi D, Choetso T, Chodon T, Parmar M, Singla R, Paster Z, Chaisson RE, Kaushal KC. High prevalence of rifampin-resistant tuberculosis in mountainous districts of India. The Indian Journal of Tuberculosis. 67: 59-64. PMID 32192619 DOI: 10.1016/J.Ijtb.2019.08.005 |
0.4 |
|
| 2020 |
Lienhardt C, Nunn A, Chaisson R, Vernon AA, Zignol M, Nahid P, Delaporte E, Kasaeva T. Advances in clinical trial design: Weaving tomorrow's TB treatments. Plos Medicine. 17: e1003059. PMID 32106220 DOI: 10.1371/Journal.Pmed.1003059 |
0.351 |
|
| 2020 |
Shin H, Ngwira LG, Tucker A, Chaisson RE, Corbett EL, Dowdy D. Patient-incurred cost of inpatient treatment for tuberculosis in rural Malawi. Tropical Medicine & International Health : Tm & Ih. PMID 32034984 DOI: 10.1111/Tmi.13381 |
0.396 |
|
| 2020 |
Dias BDC, Paximadis M, Martinson N, Chaisson RE, Ebrahim O, Tiemessen CT. The impact of bone marrow stromal antigen-2 (BST2) gene variants on HIV-1 control in black South African individuals. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 80: 104216. PMID 32006707 DOI: 10.1016/J.Meegid.2020.104216 |
0.393 |
|
| 2020 |
Dorman SE, Nahid P, Kurbatova EV, Goldberg SV, Bozeman L, Burman WJ, Chang KC, Chen M, Cotton M, Dooley KE, Engle M, Feng PJ, Fletcher CV, Ha P, Heilig CM, ... ... Chaisson RE, et al. High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial. Contemporary Clinical Trials. 105938. PMID 31981713 DOI: 10.1016/J.Cct.2020.105938 |
0.605 |
|
| 2019 |
Abdelwahab MT, Leisegang R, Dooley KE, Mathad JS, Wiesner L, McIlleron H, Martinson N, Waja Z, Letutu M, Chaisson RE, Denti P. Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in South African Pregnant Women with Tuberculosis and HIV. Antimicrobial Agents and Chemotherapy. PMID 31844002 DOI: 10.1128/Aac.01978-19 |
0.633 |
|
| 2019 |
Chaisson LH, Saraceni V, Cohn S, Seabrook D, Cavalcante S, Chaisson RE, Golub J, Durovni B. CD4 count stratification to guide tuberculosis preventive therapy for people living with HIV. Aids (London, England). PMID 31634189 DOI: 10.1097/Qad.0000000000002398 |
0.487 |
|
| 2019 |
Salazar-Austin N, Cohn S, Lala S, Waja Z, Dooley KE, Hoffmann CJ, Chaisson RE, Martinson N. Isoniazid Preventive Therapy and Pregnancy Outcomes In HIV-Infected Women in the Tshepiso Cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31631221 DOI: 10.1093/Cid/Ciz1024 |
0.634 |
|
| 2019 |
Kendall EA, Durovni B, Martinson NA, Cavalacante S, Masonoke K, Saraceni V, Lebina L, Efron A, Cohn S, Chon S, Chaisson RE, Dowdy DW, Golub JE. Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV. Aids (London, England). PMID 31567163 DOI: 10.1097/Qad.0000000000002380 |
0.501 |
|
| 2019 |
Mzingwane ML, Hunt G, Lassauniere R, Kalimashe M, Bongwe A, Ledwaba J, Chaisson RE, Martinson N, Richter K, Bowyer SM, Tiemessen CT. Detection and molecular characterization of urinary tract HIV-1 populations. Annals of Clinical Microbiology and Antimicrobials. 18: 27. PMID 31551072 DOI: 10.1186/S12941-019-0326-9 |
0.448 |
|
| 2019 |
Chaisson RE, Ramchandani R, Swindells S. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply. The New England Journal of Medicine. 381: e23. PMID 31509690 DOI: 10.1056/NEJMc1908492#sa2 |
0.442 |
|
| 2019 |
Salazar-Austin N, Dowdy DW, Chaisson RE, Golub JE. 70 years of TB Prevention: Efficacy, Effectiveness, Toxicity, Durability and Duration. American Journal of Epidemiology. PMID 31364692 DOI: 10.1093/Aje/Kwz172 |
0.487 |
|
| 2019 |
Salazar-Austin N, Cohn S, Barnes GL, Tladi M, Motlhaoleng K, Swanepoel C, Motala Z, Variava E, Martinson N, Chaisson RE. Improving TPT Uptake: A Cluster-Randomized Trial of Symptom-Based Versus Tuberculin Skin Test-Based Screening of Household Tuberculosis Contacts Less than 5 Years of Age. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31127284 DOI: 10.1093/Cid/Ciz436 |
0.369 |
|
| 2019 |
Koor GW, Paximadis M, Picton ACP, Karatas F, Loubser SA, He W, Ahuja SK, Chaisson RE, Martinson N, Ebrahim O, Tiemessen CT. Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans. Clinical Immunology (Orlando, Fla.). PMID 31100442 DOI: 10.1016/J.Clim.2019.05.009 |
0.355 |
|
| 2019 |
Hatherill M, Chaisson RE, Denkinger CM. Addressing critical needs in the fight to end tuberculosis with innovative tools and strategies. Plos Medicine. 16: e1002795. PMID 31039150 DOI: 10.1371/Journal.Pmed.1002795 |
0.351 |
|
| 2019 |
Saini V, Ammerman NC, Chang YS, Tasneen R, Chaisson RE, Jain S, Nuermberger E, Grosset JH. Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis. Antimicrobial Agents and Chemotherapy. PMID 30936097 DOI: 10.1128/Aac.00388-19 |
0.408 |
|
| 2019 |
Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, et al. Building a tuberculosis-free world: The Lancet Commission on tuberculosis. Lancet (London, England). PMID 30904263 DOI: 10.1016/S0140-6736(19)30024-8 |
0.465 |
|
| 2019 |
Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz J, Mwelase N, Jean Juste MA, Lama JR, Valencia J, Omoz-Oarhe A, Supparatpinyo K, Masheto G, Mohapi L, da Silva Escada RO, Mawlana S, ... ... Chaisson RE, et al. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. The New England Journal of Medicine. 380: 1001-1011. PMID 30865794 DOI: 10.1056/Nejmoa1806808 |
0.565 |
|
| 2018 |
Lassaunière R, Paximadis M, Ebrahim O, Chaisson RE, Martinson NA, Tiemessen CT. The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progression. Genes and Immunity. PMID 30563969 DOI: 10.1038/S41435-018-0053-9 |
0.414 |
|
| 2018 |
Dorjee K, Topgyal S, Dorjee C, Tsundue T, Namdol T, Tsewang T, Nangsel T, Lhadon D, Choetso T, Dawa T, Phentok T, DeLuca AN, Tsering L, Phunkyi D, Sadutshang TD, ... ... Chaisson RE, et al. High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30462191 DOI: 10.1093/Cid/Ciy987 |
0.374 |
|
| 2018 |
Denholm JT, Silva DS, Burhan E, Chaisson RE. Tuberculosis Elimination in the Asia-Pacific Region and the WHO Ethics Guidance. Tropical Medicine and Infectious Disease. 3. PMID 30384409 DOI: 10.3390/Tropicalmed3040115 |
0.373 |
|
| 2018 |
Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, Gendelman HE, Gordon R, Hesseling A, Hoi LV, Kampmann B, Kana B, Khuller G, Lewinsohn DM, Lewinsohn DA, et al. Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection. American Journal of Respiratory and Critical Care Medicine. PMID 30335466 DOI: 10.1164/Rccm.201806-1053Pp |
0.485 |
|
| 2018 |
Ngwira LG, Corbett EL, Khundi M, Barnes GL, Nkhoma A, Murowa M, Cohn S, Moulton LH, Chaisson RE, Dowdy DW. Screening for tuberculosis with Xpert MTB/RIF versus fluorescent microscopy among adults newly diagnosed with HIV in rural Malawi: a cluster randomized trial (CHEPETSA). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30059995 DOI: 10.1093/Cid/Ciy590 |
0.523 |
|
| 2018 |
Little KM, Msandiwa R, Martinson N, Golub J, Chaisson R, Dowdy D. Yield of household contact tracing for tuberculosis in rural South Africa. Bmc Infectious Diseases. 18: 299. PMID 29973140 DOI: 10.1186/S12879-018-3193-7 |
0.428 |
|
| 2018 |
Ammerman NC, Swanson RV, Bautista EM, Almeida DV, Saini V, Omansen TF, Guo H, Chang YS, Li SY, Tapley A, Tasneen R, Tyagi S, Betoudji F, Moodley C, Ngcobo B, ... ... Chaisson RE, et al. Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. PMID 29735562 DOI: 10.1128/Aac.00636-18 |
0.368 |
|
| 2018 |
Irvin R, McAdams-Mahmoud A, White J, Grant Z, Falade-Nwulia O, Sherman S, Beyrer C, Sulkowski M, Thomas DL, Mehta SH, Chaisson R. An Education and Field Experience Program to Increase Detection of Human Immunodeficiency Virus and Hepatitis C Virus. Progress in Community Health Partnerships : Research, Education, and Action. 12: 101-109. PMID 29606698 DOI: 10.1353/Cpr.2018.0011 |
0.336 |
|
| 2018 |
Little KM, Khundi M, Barnes GL, Ngwira LG, Nkhoma A, Makombe S, Corbett EL, Chaisson RE, Dowdy DW. Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 22: 371-377. PMID 29562983 DOI: 10.5588/Ijtld.16.0836 |
0.542 |
|
| 2018 |
Ngwira LG, Dowdy DW, Khundi M, Barnes GL, Nkhoma A, Choko AT, Murowa M, Chaisson RE, Corbett EL, Fielding K. Delay in seeking care for tuberculosis symptoms among adults newly diagnosed with HIV in rural Malawi. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 22: 280-286. PMID 29471905 DOI: 10.5588/Ijtld.17.0539 |
0.423 |
|
| 2018 |
Moro RN, Scott NA, Vernon A, Tepper NK, Goldberg SV, Schwartzman K, Leung CC, Schluger NW, Belknap RW, Chaisson RE, Narita M, Machado ES, Lopez M, Sanchez J, Villarino ME, et al. Exposure to Latent Tuberculosis Treatment during Pregnancy: The PREVENT TB and the iAdhere Trials. Annals of the American Thoracic Society. PMID 29393655 DOI: 10.1513/Annalsats.201704-326Oc |
0.419 |
|
| 2017 |
Salazar-Austin N, Hoffmann J, Cohn S, Mashabela F, Waja Z, Lala S, Hoffmann C, Dooley KE, Chaisson RE, Martinson N. Poor Obstetric and Infant Outcomes in HIV-Infected Pregnant Women with Tuberculosis in South Africa: The Tshepiso Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29028970 DOI: 10.1093/Cid/Cix851 |
0.698 |
|
| 2017 |
Chaisson RE, Golub JE. Preventing tuberculosis in people with HIV-no more excuses. The Lancet. Global Health. 5: e1048-e1049. PMID 29025618 DOI: 10.1016/S2214-109X(17)30390-X |
0.529 |
|
| 2017 |
Adu-Gyamfi CG, Snyman T, Hoffmann CJ, Martinson NA, Chaisson RE, George JA, Suchard MS. Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 65: 1356-1358. PMID 29017244 DOI: 10.1093/Cid/Cix550 |
0.507 |
|
| 2017 |
Gupte AN, Wong ML, Msandiwa R, Barnes GL, Golub J, Chaisson RE, Hoffmann CJ, Martinson NA. Factors associated with pulmonary impairment in HIV-infected South African adults. Plos One. 12: e0184530. PMID 28902919 DOI: 10.1371/Journal.Pone.0184530 |
0.456 |
|
| 2017 |
Picton ACP, Paximadis M, Chaisson RE, Martinson NA, Tiemessen CT. CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individuals. Clinical Immunology (Orlando, Fla.). PMID 28428094 DOI: 10.1016/J.Clim.2017.04.006 |
0.332 |
|
| 2017 |
McIlleron H, Denti P, Cohn S, Mashabela F, Hoffmann JD, Shembe S, Msandiwa R, Wiesner L, Velaphi S, Lala SG, Chaisson RE, Martinson N, Dooley KE. Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants. The Journal of Antimicrobial Chemotherapy. PMID 28419277 DOI: 10.1093/Jac/Dkx112 |
0.683 |
|
| 2017 |
Moro RN, Sterling TR, Saukkonen J, Vernon A, Horsburgh CR, Chaisson RE, Hamilton CD, Villarino ME, Goldberg S. Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. PMID 28087928 DOI: 10.5588/Ijtld.16.0469 |
0.305 |
|
| 2017 |
Paximadis M, Ngqobe RN, Chaisson RE, Martinson NA, Tiemessen CT. RICH2 is implicated in viraemic control of HIV-1 in black South African individuals. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. PMID 28069446 DOI: 10.1016/J.Meegid.2017.01.007 |
0.353 |
|
| 2016 |
Alipanah N, Cattamanchi A, Menzies R, Hopewell PC, Chaisson RE, Nahid P. Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 20: 1522-1528. PMID 27776595 DOI: 10.5588/Ijtld.16.0217 |
0.441 |
|
| 2016 |
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, et al. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 63: 853-67. PMID 27621353 DOI: 10.1093/cid/ciw566 |
0.34 |
|
| 2016 |
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27516382 DOI: 10.1093/Cid/Ciw376 |
0.448 |
|
| 2016 |
Sterling TR, Scott NA, Miro JM, Calvet G, La Rosa A, Infante R, Chen MP, Benator DA, Gordin F, Benson CA, Chaisson RE, Villarino ME. Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons. Aids (London, England). 30: 1607-1615. PMID 27243774 DOI: 10.1097/Qad.0000000000001098 |
0.518 |
|
| 2016 |
Conde MB, Mello FC, Duarte RS, Cavalcante SC, Rolla V, Dalcolmo M, Loredo C, Durovni B, Armstrong DT, Efron A, Barnes GL, Marzinke MA, Savic RM, Dooley KE, Cohn S, ... ... Chaisson RE, et al. A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis. Plos One. 11: e0154778. PMID 27159505 DOI: 10.1371/Journal.Pone.0154778 |
0.636 |
|
| 2016 |
Sterling TR, Scott NA, Miro JM, Calvet G, La Rosa A, Infante R, Chen MP, Benator DA, Gordin F, Benson CA, Chaisson RE, Villarino ME. Three months of weekly rifapentine plus isoniazid for treatment of M. tuberculosis infection in HIV co-infected persons. Aids (London, England). PMID 26990624 DOI: 10.1097/QAD.0000000000001098 |
0.404 |
|
| 2016 |
Dierberg KL, Dorjee K, Salvo F, Cronin WA, Boddy J, Cirillo D, Sadutshang T, Chaisson RE. Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India. Emerging Infectious Diseases. 22. PMID 26889728 DOI: 10.3201/Eid2203.140732 |
0.421 |
|
| 2016 |
Lanoix JP, Chaisson RE, Nuermberger EL. Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: 484-90. PMID 26527614 DOI: 10.1093/Cid/Civ911 |
0.36 |
|
| 2016 |
Chaisson R. A-111 Controlling the impact of HIV-related tuberculosis Jaids Journal of Acquired Immune Deficiency Syndromes. 71: 39. DOI: 10.1097/01.Qai.0000479584.45378.9F |
0.506 |
|
| 2015 |
Denti P, Martinson N, Cohn S, Mashabela F, Hoffmann J, Msandiwa R, Castel S, Wiesner L, Chaisson RE, McIlleron H, Dooley KE. Population pharmacokinetics of rifampicin in pregnant women with tuberculosis and HIV co-infection in Soweto, South Africa. Antimicrobial Agents and Chemotherapy. PMID 26643345 DOI: 10.1128/Aac.02051-15 |
0.624 |
|
| 2015 |
Rangaka MX, Cavalcante SC, Marais BJ, Thim S, Martinson NA, Swaminathan S, Chaisson RE. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet (London, England). PMID 26515679 DOI: 10.1016/S0140-6736(15)00323-2 |
0.485 |
|
| 2015 |
Omar T, Variava E, Moroe E, Billioux A, Chaisson RE, Lebina L, Martinson N. Undiagnosed TB in adults dying at home from natural causes in a high TB burden setting: a post-mortem study. International Journal of Tuberculosis and Lung Disease. 19: 1320-1325. PMID 26467584 DOI: 10.5588/Ijtld.15.0222 |
0.499 |
|
| 2015 |
Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. The European Respiratory Journal. PMID 26405286 DOI: 10.1183/13993003.01245-2015 |
0.514 |
|
| 2015 |
Lala SG, Little KM, Tshabangu N, Moore DP, Msandiwa R, van der Watt M, Chaisson RE, Martinson NA. Integrated Source Case Investigation for Tuberculosis (TB) and HIV in the Caregivers and Household Contacts of Hospitalised Young Children Diagnosed with TB in South Africa: An Observational Study. Plos One. 10: e0137518. PMID 26378909 DOI: 10.1371/Journal.Pone.0137518 |
0.522 |
|
| 2015 |
Getahun H, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis Infection. The New England Journal of Medicine. 373: 1179-80. PMID 26376149 DOI: 10.1056/Nejmc1508223 |
0.442 |
|
| 2015 |
Hoffmann CJ, Cohn S, Mashabela F, Hoffmann JD, McIlleron H, Denti P, Haas D, Dooley KE, Martinson NA, Chaisson RE. Treatment failure, drug resistance, and CD4 T-cell count decline among postpartum women on antiretroviral therapy in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26334739 DOI: 10.1097/Qai.0000000000000811 |
0.595 |
|
| 2015 |
Podany AT, Bao Y, Swindells S, Chaisson RE, Andersen JW, Mwelase T, Supparatpinyo K, Mohapi L, Gupta A, Benson CA, Kim P, Fletcher CV. Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26082504 DOI: 10.1093/Cid/Civ464 |
0.564 |
|
| 2015 |
Dawson R, Narunsky K, Carman D, Gupte N, Whitelaw A, Efron A, Barnes GL, Hoffman J, Chaisson RE, McIlleron H, Dorman SE. Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 19: 780-6. PMID 26056101 DOI: 10.5588/Ijtld.14.0868 |
0.355 |
|
| 2015 |
Zwerling AA, Sahu M, Ngwira LG, Khundi M, Harawa T, Corbett EL, Chaisson RE, Dowdy DW. Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness Analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 70: 83-90. PMID 26049281 DOI: 10.1097/Qai.0000000000000712 |
0.464 |
|
| 2015 |
Amoakwa K, Martinson NA, Moulton LH, Barnes GL, Msandiwa R, Chaisson RE. Risk factors for developing active tuberculosis after the treatment of latent tuberculosis in adults infected with human immunodeficiency virus. Open Forum Infectious Diseases. 2: ofu120. PMID 26034751 DOI: 10.1093/Ofid/Ofu120 |
0.522 |
|
| 2015 |
Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. The New England Journal of Medicine. 372: 2127-35. PMID 26017823 DOI: 10.1056/Nejmra1405427 |
0.463 |
|
| 2015 |
Hoffmann CJ, Hoffmann JD, Kensler C, van der Watt M, Omar T, Chaisson RE, Martinson NA, Variava E. Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South Africa. Plos One. 10: e0117813. PMID 25668620 DOI: 10.1371/Journal.Pone.0117813 |
0.489 |
|
| 2015 |
Golub JE, Cohn S, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, Durovni B, Chaisson RE. Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 639-45. PMID 25365974 DOI: 10.1093/Cid/Ciu849 |
0.574 |
|
| 2015 |
Dooley KE, Denti P, Martinson N, Cohn S, Mashabela F, Hoffmann J, Haas DW, Hull J, Msandiwa R, Castel S, Wiesner L, Chaisson RE, McIlleron H. Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection. The Journal of Infectious Diseases. 211: 197-205. PMID 25081933 DOI: 10.1093/Infdis/Jiu429 |
0.674 |
|
| 2015 |
Scharfstein D, Rotnitzky A, Abraham M, McDermott A, Chaisson R, Geiter L. On the analysis of tuberculosis studies with intermittent missing sputum data The Annals of Applied Statistics. 9: 2215-2236. DOI: 10.1214/15-Aoas860 |
0.422 |
|
| 2014 |
Azadi M, Bishai DM, Dowdy DW, Moulton LH, Cavalcante S, Saraceni V, Pacheco AG, Cohn S, Chaisson RE, Durovni B, Golub JE. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 18: 1443-8. PMID 25517809 DOI: 10.5588/Ijtld.14.0108 |
0.53 |
|
| 2014 |
Churchyard GJ, Chaisson RE, Maartens G, Getahun H. Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde. 104: 339-43. PMID 25212199 DOI: 10.7196/Samj.8290 |
0.545 |
|
| 2014 |
Chaisson RE, Post WS. Immunotherapy for tuberculous pericarditis. The New England Journal of Medicine. 371: 1155-7. PMID 25178808 DOI: 10.1056/Nejme1409356 |
0.478 |
|
| 2014 |
Tiam A, Machekano R, Gounder CR, Maama-Maime LB, Ntene-Sealiete K, Sahu M, Isavwa A, Oyebanji O, Ahimbisibwe A, Mokone M, Barnes GL, Chaisson RE, Guay L, Kassaye S. Preventing tuberculosis among HIV-infected pregnant women in Lesotho: the case for rolling out active case finding and isoniazid preventive therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 67: e5-e11. PMID 25118796 DOI: 10.1097/Qai.0000000000000209 |
0.437 |
|
| 2014 |
Saraceni V, Durovni B, Pacheco AG, Chaisson RE, Golub JE. Reply to "at the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection". The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases. 18: 578-9. PMID 25108220 DOI: 10.1016/J.Bjid.2014.07.001 |
0.52 |
|
| 2014 |
Saraceni V, Cohn S, Cavalcante SC, Pacheco AG, Moulton LH, Chaisson RE, Durovni B, Golub JE. Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 98-101. PMID 24933097 DOI: 10.1097/Qai.0000000000000247 |
0.542 |
|
| 2014 |
Salvo F, Dorjee K, Dierberg K, Cronin W, Sadutshang TD, Migliori GB, Rodrigues C, Trentini F, Serio CD, Chaisson R, Cirillo DM. Survey of tuberculosis drug resistance among Tibetan refugees in India. International Journal of Tuberculosis and Lung Disease. 18: 655-662. PMID 24903934 DOI: 10.5588/Ijtld.13.0516 |
0.428 |
|
| 2014 |
Hoffmann CJ, Mashabela F, Cohn S, Hoffmann JD, Lala S, Martinson NA, Chaisson RE. Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa. Journal of the International Aids Society. 17: 18871. PMID 24855985 DOI: 10.7448/Ias.17.1.18871 |
0.347 |
|
| 2014 |
Dowdy DW, Golub JE, Saraceni V, Moulton LH, Cavalcante SC, Cohn S, Pacheco AG, Chaisson RE, Durovni B. Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 552-8. PMID 24853308 DOI: 10.1097/Qai.0000000000000219 |
0.468 |
|
| 2014 |
Martinson NA, Gupte N, Msandiwa R, Moulton LH, Barnes GL, Ram M, Gray G, Hoffmann C, Chaisson RE. CD4 and viral load dynamics in antiretroviral-naïve HIV-infected adults from Soweto, South Africa: a prospective cohort. Plos One. 9: e96369. PMID 24831447 DOI: 10.1371/Journal.Pone.0096369 |
0.405 |
|
| 2014 |
Saraceni V, Durovni B, Cavalcante SC, Cohn S, Pacheco AG, Moulton LH, Chaisson RE, Golub JE. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil. The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases. 18: 491-5. PMID 24780362 DOI: 10.1016/J.Bjid.2014.02.004 |
0.563 |
|
| 2014 |
Hoffmann CJ, Charalambous S, Grant AD, Morris L, Churchyard GJ, Chaisson RE. Durable HIV RNA resuppression after virologic failure while remaining on a first-line regimen: a cohort study. Tropical Medicine & International Health : Tm & Ih. 19: 236-9. PMID 24588012 DOI: 10.1111/Tmi.12237 |
0.405 |
|
| 2014 |
Beyrer C, Baral SD, Weir BW, Curran JW, Chaisson RE, Sullivan PS. A call to action for concentrated HIV epidemics. Current Opinion in Hiv and Aids. 9: 95-100. PMID 24499807 DOI: 10.1097/Coh.0000000000000043 |
0.363 |
|
| 2014 |
Churchyard GJ, Fielding KL, Lewis JJ, Coetzee L, Corbett EL, Godfrey-Faussett P, Hayes RJ, Chaisson RE, Grant AD. A trial of mass isoniazid preventive therapy for tuberculosis control. The New England Journal of Medicine. 370: 301-10. PMID 24450889 DOI: 10.1056/NEJMoa1214289 |
0.346 |
|
| 2014 |
Hoffmann CJ, Chaisson RE, Martinson NA. Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV. Plos One. 9: e83750. PMID 24421903 DOI: 10.1371/Journal.Pone.0083750 |
0.546 |
|
| 2013 |
Durovni B, Saraceni V, Moulton LH, Pacheco AG, Cavalcante SC, King BS, Cohn S, Efron A, Chaisson RE, Golub JE. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. The Lancet. Infectious Diseases. 13: 852-8. PMID 23954450 DOI: 10.1016/S1473-3099(13)70187-7 |
0.549 |
|
| 2013 |
Hoffmann CJ, Ledwaba J, Li JF, Johnston V, Hunt G, Fielding KL, Chaisson RE, Churchyard GJ, Grant AD, Johnson JA, Charalambous S, Morris L. Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa. Antiviral Therapy. 18: 915-20. PMID 23751421 DOI: 10.3851/Imp2652 |
0.47 |
|
| 2013 |
Dierberg KL, Chaisson RE. Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment. Clinics in Chest Medicine. 34: 217-28. PMID 23702172 DOI: 10.1016/J.Ccm.2013.02.003 |
0.576 |
|
| 2013 |
Hoffmann CJ, Variava E, Rakgokong M, Masonoke K, van der Watt M, Chaisson RE, Martinson NA. High prevalence of pulmonary tuberculosis but low sensitivity of symptom screening among HIV-infected pregnant women in South Africa. Plos One. 8: e62211. PMID 23614037 DOI: 10.1371/Journal.Pone.0062211 |
0.492 |
|
| 2013 |
Hales CM, Heilig CM, Chaisson R, Leung CC, Chang KC, Goldberg SV, Gordin F, Johnson JL, Muzanyi G, Saukkonen J, Vernon A, Villarino ME, Burman WJ. The association between symptoms and microbiologically defined response to tuberculosis treatment. Annals of the American Thoracic Society. 10: 18-25. PMID 23509328 DOI: 10.1513/Annalsats.201207-038Oc |
0.388 |
|
| 2013 |
Duwell MM, Knowlton AR, Nachega JB, Efron A, Goliath R, Morroni C, Maartens G, Chaisson RE. Patient-nominated, community-based HIV treatment supporters: patient perspectives, feasibility, challenges, and factors for success in HIV-infected South African adults. Aids Patient Care and Stds. 27: 96-102. PMID 23373664 DOI: 10.1089/Apc.2012.0348 |
0.403 |
|
| 2013 |
Dowdy DW, Chaisson RE. Post-2015 tuberculosis strategies in a pre-2015 world. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 17: 143. PMID 23317946 DOI: 10.5588/Ijtld.12.0966 |
0.414 |
|
| 2013 |
Otwombe KN, Variava E, Holmes CB, Chaisson RE, Martinson N. Predictors of delay in the diagnosis and treatment of suspected tuberculosis in HIV co-infected patients in South Africa International Journal of Tuberculosis and Lung Disease. 17: 1199-1205. DOI: 10.5588/Ijtld.12.0891 |
0.536 |
|
| 2012 |
Zhang Y, Chiu Chang K, Leung CC, Wai Yew W, Gicquel B, Fallows D, Kaplan G, Chaisson RE, Zhang W. 'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility. Emerging Microbes & Infections. 1: e5. PMID 26038418 DOI: 10.1038/Emi.2012.18 |
0.442 |
|
| 2012 |
Nachega JB, Morroni C, Chaisson RE, Goliath R, Efron A, Ram M, Maartens G. Impact of immune reconstitution inflammatory syndrome on antiretroviral therapy adherence. Patient Preference and Adherence. 6: 887-91. PMID 23271897 DOI: 10.2147/Ppa.S38897 |
0.392 |
|
| 2012 |
Gounder CR, Chaisson RE. A diagonal approach to building primary healthcare systems in resource-limited settings: women-centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives. Tropical Medicine & International Health : Tm & Ih. 17: 1426-31. PMID 23113824 DOI: 10.1111/J.1365-3156.2012.03100.X |
0.314 |
|
| 2012 |
Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, Sterling TR, Chaisson RE, Williams BG, Harries AD, Granich RM. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. Plos Medicine. 9: e1001270. PMID 22911011 DOI: 10.1371/Journal.Pmed.1001270 |
0.553 |
|
| 2012 |
Chaisson RE, Nuermberger EL. Confronting multidrug-resistant tuberculosis. The New England Journal of Medicine. 366: 2223-4. PMID 22670908 DOI: 10.1056/Nejme1204478 |
0.382 |
|
| 2012 |
Dowdy DW, Golub JE, Chaisson RE, Saraceni V. Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics. Proceedings of the National Academy of Sciences of the United States of America. 109: 9557-62. PMID 22645356 DOI: 10.1073/Pnas.1203517109 |
0.439 |
|
| 2012 |
Kufa T, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, Grant AD, Wada N, Chaisson RE, Churchyard GJ, Gounder CR. Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control. Journal of Acquired Immune Deficiency Syndromes (1999). 60: e22-8. PMID 22627184 DOI: 10.1097/Qai.0B013E318251Ae0B |
0.563 |
|
| 2012 |
Shapiro AE, Variava E, Rakgokong MH, Moodley N, Luke B, Salimi S, Chaisson RE, Golub JE, Martinson NA. Community-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa. American Journal of Respiratory and Critical Care Medicine. 185: 1110-6. PMID 22427532 DOI: 10.1164/Rccm.201111-1941Oc |
0.545 |
|
| 2012 |
Hsia EC, Schluger N, Cush JJ, Chaisson RE, Matteson EL, Xu S, Beutler A, Doyle MK, Hsu B, Rahman MU. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Arthritis and Rheumatism. 64: 2068-77. PMID 22238071 DOI: 10.1002/Art.34382 |
0.354 |
|
| 2012 |
Page KR, Chaisson RE, Sande M. Cryptococcosis and other fungal infections (histoplasmosis and coccidioidomycosis) in HIV-infected patients Sande's Hiv/Aids Medicine: Medical Management of Aids 2013: Second Edition. 369-388. DOI: 10.1016/B978-1-4557-0695-2.00029-8 |
0.331 |
|
| 2011 |
Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, ... ... Chaisson RE, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. The New England Journal of Medicine. 365: 2155-66. PMID 22150035 DOI: 10.1056/Nejmoa1104875 |
0.468 |
|
| 2011 |
Farley JE, Ram M, Pan W, Waldman S, Cassell GH, Chaisson RE, Weyer K, Lancaster J, Van der Walt M. Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. Plos One. 6: e20436. PMID 21799728 DOI: 10.1371/Journal.Pone.0020436 |
0.553 |
|
| 2011 |
Gounder CR, Kufa T, Wada NI, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, Grant A, Dorman S, Chaisson RE, Churchyard GJ. Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 219-23. PMID 21765364 DOI: 10.1097/Qai.0B013E31822B75D4 |
0.483 |
|
| 2011 |
Kasambira TS, Shah M, Adrian PV, Holshouser M, Madhi SA, Chaisson RE, Martinson NA, Dorman SE. QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 15: 628-34. PMID 21756513 DOI: 10.5588/Ijtld.10.0555 |
0.433 |
|
| 2011 |
Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, De Cock KM, Wood R. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? International Journal of Tuberculosis and Lung Disease. 15: 571-581. PMID 21756508 DOI: 10.5588/Ijtld.10.0483 |
0.57 |
|
| 2011 |
Martinson NA, Barnes GL, Moulton LH, Msandiwa R, Hausler H, Ram M, McIntyre JA, Gray GE, Chaisson RE. New regimens to prevent tuberculosis in adults with HIV infection. The New England Journal of Medicine. 365: 11-20. PMID 21732833 DOI: 10.1056/Nejmoa1005136 |
0.556 |
|
| 2011 |
Wilson D, Mbhele L, Badri M, Morroni C, Nachega J, Chaisson RE, Maartens G. Evaluation of the World Health Organization algorithm for the diagnosis of HIV-associated sputum smear-negative tuberculosis. International Journal of Tuberculosis and Lung Disease. 15: 919-924. PMID 21682965 DOI: 10.5588/Ijtld.10.0440 |
0.357 |
|
| 2011 |
Saraceni V, Pacheco AG, Golub JE, Vellozo V, King BS, Cavalcante SC, Eldred L, Chaisson RE, Durovni B. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil. The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases. 15: 249-52. PMID 21670926 DOI: 10.1016/S1413-8670(11)70184-2 |
0.551 |
|
| 2011 |
Martinson NA, Hoffmann CJ, Chaisson RE. Epidemiology of tuberculosis and HIV: recent advances in understanding and responses. Proceedings of the American Thoracic Society. 8: 288-93. PMID 21653530 DOI: 10.1513/pats.201010-064WR |
0.496 |
|
| 2011 |
Crothers K, Thompson BW, Burkhardt K, Morris A, Flores SC, Diaz PT, Chaisson RE, Kirk GD, Rom WN, Huang L. HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proceedings of the American Thoracic Society. 8: 275-81. PMID 21653528 DOI: 10.1513/pats.201009-059WR |
0.334 |
|
| 2011 |
Martinson NA, Chaisson RE. Survival in XDR TB: shifting the curve and shifting the paradigm. Journal of Acquired Immune Deficiency Syndromes (1999). 57: 89-91. PMID 21522018 DOI: 10.1097/Qai.0B013E31821B4B42 |
0.563 |
|
| 2011 |
Gounder CR, Wada NI, Kensler C, Violari A, McIntyre J, Chaisson RE, Martinson NA. Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in Soweto, South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). 57: e77-84. PMID 21436710 DOI: 10.1097/Qai.0B013E31821Ac9C1 |
0.521 |
|
| 2011 |
Nachega JB, Rosenkranz B, Simon G, Chaisson RE, Diacon A, Taljaard J. Management of adult active tuberculosis disease in era of HIV pandemic, current practices and future perspectives. Infectious Disorders Drug Targets. 11: 134-43. PMID 21406051 DOI: 10.2174/187152611795589726 |
0.526 |
|
| 2011 |
Fielding KL, Grant AD, Hayes RJ, Chaisson RE, Corbett EL, Churchyard GJ. Thibela TB: design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa. Contemporary Clinical Trials. 32: 382-92. PMID 21193066 DOI: 10.1016/J.Cct.2010.12.008 |
0.536 |
|
| 2011 |
Churchyard GJ, Fielding K, Roux S, Corbett EL, Chaisson RE, De Cock KM, Hayes RJ, Grant AD. Twelve-monthly versus six-monthly radiological screening for active case-finding of tuberculosis: a randomised controlled trial. Thorax. 66: 134-9. PMID 21098802 DOI: 10.1136/Thx.2010.139048 |
0.353 |
|
| 2011 |
Pacheco AG, Saraceni V, Tuboi SH, Lauria LM, Moulton LH, Faulhaber JC, King B, Golub JE, Durovni B, Cavalcante S, Harrison LH, Chaisson RE, Schechter M. Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil. Aids Research and Human Retroviruses. 27: 25-8. PMID 20929394 DOI: 10.1089/Aid.2010.0089 |
0.459 |
|
| 2010 |
Durovni B, Cavalcante SC, Saraceni V, Vellozo V, Israel G, King BS, Cohn S, Efron A, Pacheco AG, Moulton LH, Chaisson RE, Golub JE. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. Aids (London, England). 24: S49-56. PMID 21079428 DOI: 10.1097/01.Aids.0000391022.95412.A6 |
0.538 |
|
| 2010 |
Grant AD, Fielding KL, Charalambous S, Chaisson RE, Churchyard GJ. Why have trials of isoniazid preventive therapy among people with HIV infection not demonstrated an effect on mortality?: did close examination of the trees obscure our view of the wood? Aids (London, England). 24: S15-8. PMID 21079423 DOI: 10.1097/01.Aids.0000391011.40892.Ff |
0.451 |
|
| 2010 |
Eldred LJ, Churchyard G, Durovni B, Godfrey-Faussett P, Grant AD, Getahun H, Chaisson RE. Isoniazid preventive therapy for HIV-infected people: evidence to support implementation. Aids (London, England). 24: S1-3. PMID 21079422 DOI: 10.1097/01.Aids.0000391009.95149.Ec |
0.469 |
|
| 2010 |
Chaisson RE, Harrington M. How research can help control tuberculosis World Hospitals and Health Services : the Official Journal of the International Hospital Federation. 46: 33-40. PMID 20614683 |
0.307 |
|
| 2010 |
Shah M, Martinson NA, Chaisson RE, Martin DJ, Variava E, Dorman SE. Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. Journal of Clinical Microbiology. 48: 2972-4. PMID 20534796 DOI: 10.1128/Jcm.00363-10 |
0.48 |
|
| 2010 |
Hanrahan CF, Golub JE, Mohapi L, Tshabangu N, Modisenyane T, Chaisson RE, Gray GE, McIntyre JA, Martinson NA. Body mass index and risk of tuberculosis and death. Aids (London, England). 24: 1501-8. PMID 20505496 DOI: 10.1097/Qad.0B013E32833A2A4A |
0.433 |
|
| 2010 |
Hoffmann CJ, Fielding KL, Charalambous S, Innes C, Chaisson RE, Grant AD, Churchyard GJ. Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa. Aids (London, England). 24: 1709-16. PMID 20495439 DOI: 10.1097/Qad.0B013E32833Ac6Bc |
0.308 |
|
| 2010 |
Nachega JB, Chaisson RE, Goliath R, Efron A, Chaudhary MA, Ram M, Morroni C, Schoeman H, Knowlton AR, Maartens G. Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy. Aids (London, England). 24: 1273-80. PMID 20453627 DOI: 10.1097/Qad.0B013E328339E20E |
0.328 |
|
| 2010 |
Sterling TR, Pham PA, Chaisson RE. HIV infection-related tuberculosis: clinical manifestations and treatment. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: S223-30. PMID 20397952 DOI: 10.1086/651495 |
0.578 |
|
| 2010 |
Pope DS, Atkins S, DeLuca AN, Hausler H, Hoosain E, Celentano DD, Chaisson RE. South African TB nurses' experiences of provider-initiated HIV counseling and testing in the Eastern Cape Province: a qualitative study. Aids Care. 22: 238-45. PMID 20390502 DOI: 10.1080/09540120903040594 |
0.767 |
|
| 2010 |
Chaisson RE, Churchyard GJ. Recurrent tuberculosis: relapse, reinfection, and HIV. The Journal of Infectious Diseases. 201: 653-5. PMID 20121432 DOI: 10.1086/650531 |
0.532 |
|
| 2009 |
Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet. Infectious Diseases. 9: 737-46. PMID 19926034 DOI: 10.1016/S1473-3099(09)70282-8 |
0.6 |
|
| 2009 |
Hoffmann CJ, Charalambous S, Sim J, Ledwaba J, Schwikkard G, Chaisson RE, Fielding KL, Churchyard GJ, Morris L, Grant AD. Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1928-35. PMID 19911963 DOI: 10.1086/648444 |
0.409 |
|
| 2009 |
Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, Dorman SE, Martinson NA. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 145-51. PMID 19692904 DOI: 10.1097/Qai.0B013E3181B98430 |
0.513 |
|
| 2009 |
Golub JE, Chaisson RE, Martinson NA. Additive effects of isoniazid preventive therapy and HAART. Aids (London, England). 23: 1446-7. PMID 19564725 DOI: 10.1097/Qad.0B013E32832D53Fc |
0.465 |
|
| 2009 |
Dowdy DW, Chaisson RE. The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection. Bulletin of the World Health Organization. 87: 296-304. PMID 19551238 DOI: 10.2471/Blt.08.054510 |
0.374 |
|
| 2009 |
Golub JE, Pronyk P, Mohapi L, Thsabangu N, Moshabela M, Struthers H, Gray GE, McIntyre JA, Chaisson RE, Martinson NA. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. Aids (London, England). 23: 631-6. PMID 19525621 DOI: 10.1097/Qad.0B013E328327964F |
0.54 |
|
| 2009 |
Hoffmann CJ, Charalambous S, Fielding KL, Innes C, Chaisson RE, Grant AD, Churchyard GJ. HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South Africa. Aids (London, England). 23: 1784-6. PMID 19491652 DOI: 10.1097/Qad.0B013E32832E0585 |
0.408 |
|
| 2009 |
Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, ... ... Chaisson RE, et al. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180: 273-80. PMID 19406981 DOI: 10.1164/Rccm.200901-0078Oc |
0.427 |
|
| 2009 |
Conde MB, Efron A, Loredo C, De Souza GR, Graça NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, Chaisson RE. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet (London, England). 373: 1183-9. PMID 19345831 DOI: 10.1016/S0140-6736(09)60333-0 |
0.398 |
|
| 2009 |
Ribeiro S, Dooley K, Hackman J, Loredo C, Efron A, Chaisson RE, Conde MB, Boechat N, Dorman SE. T-SPOT.TB responses during treatment of pulmonary tuberculosis. Bmc Infectious Diseases. 9: 23. PMID 19250549 DOI: 10.1186/1471-2334-9-23 |
0.615 |
|
| 2009 |
Deluca A, Chaisson RE, Martinson NA. Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health. Journal of Acquired Immune Deficiency Syndromes (1999). 50: 196-9. PMID 19131888 DOI: 10.1097/Qai.0B013E3181900201 |
0.55 |
|
| 2009 |
Dowdy DW, Chaisson RE. Persistencia de la tuberculosis en la era DOTS: reevaluación del efecto de la detección de casos Bulletin of the World Health Organization. 87: 296-304. DOI: 10.1590/S0042-96862009000400015 |
0.302 |
|
| 2009 |
Chaisson RE, Chaudhary MA, Conde MB. Moxifloxacin versus ethambutol in initial tuberculosis treatment - Authors' reply The Lancet. 373: 2198-2199. DOI: 10.1016/S0140-6736(09)61190-9 |
0.419 |
|
| 2008 |
Dowdy DW, Lourenço MC, Cavalcante SC, Saraceni V, King B, Golub JE, Bishai D, Durovni B, Chaisson RE, Dorman SE. Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. Plos One. 3: e4057. PMID 19129940 DOI: 10.1371/Journal.Pone.0004057 |
0.466 |
|
| 2008 |
Golub JE, Durovni B, King BS, Cavalacante SC, Pacheco AG, Moulton LH, Moore RD, Chaisson RE, Saraceni V. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. Aids (London, England). 22: 2527-33. PMID 19005276 DOI: 10.1097/Qad.0B013E328311Ac4E |
0.534 |
|
| 2008 |
Golub JE, Astemborski J, Ahmed M, Cronin W, Mehta SH, Kirk GD, Vlahov D, Chaisson RE. Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 49: 532-7. PMID 18989223 DOI: 10.1097/Qai.0B013E31818D5C1C |
0.442 |
|
| 2008 |
Hoffmann CJ, Charalambous S, Martin DJ, Innes C, Churchyard GJ, Chaisson RE, Grant AD, Fielding KL, Thio CL. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 47: 1479-85. PMID 18937580 DOI: 10.1086/593104 |
0.394 |
|
| 2008 |
Pacheco AG, Saraceni V, Tuboi SH, Moulton LH, Chaisson RE, Cavalcante SC, Durovni B, Faulhaber JC, Golub JE, King B, Schechter M, Harrison LH. Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil. American Journal of Epidemiology. 168: 1326-32. PMID 18849301 DOI: 10.1093/Aje/Kwn249 |
0.38 |
|
| 2008 |
Nachega JB, Hislop M, Dowdy DW, Gallant JE, Chaisson RE, Regensberg L, Maartens G. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. Aids (London, England). 22: 2117-25. PMID 18832875 DOI: 10.1097/Qad.0B013E328310407E |
0.433 |
|
| 2008 |
Pacheco AG, Durovni B, Cavalcante SC, Lauria LM, Moore RD, Moulton LH, Chaisson RE, Golub JE. AIDS-related tuberculosis in Rio de Janeiro, Brazil. Plos One. 3: e3132. PMID 18781195 DOI: 10.1371/Journal.Pone.0003132 |
0.515 |
|
| 2008 |
Dooley K, Flexner C, Hackman J, Peloquin CA, Nuermberger E, Chaisson RE, Dorman SE. Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations. Antimicrobial Agents and Chemotherapy. 52: 4037-42. PMID 18765687 DOI: 10.1128/Aac.00554-08 |
0.543 |
|
| 2008 |
Dowdy DW, Chaisson RE, Maartens G, Corbett EL, Dorman SE. Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proceedings of the National Academy of Sciences of the United States of America. 105: 11293-8. PMID 18695217 DOI: 10.1073/Pnas.0800965105 |
0.472 |
|
| 2008 |
Pope DS, Deluca AN, Kali P, Hausler H, Sheard C, Hoosain E, Chaudhary MA, Celentano DD, Chaisson RE. A cluster-randomized trial of provider-initiated (opt-out) HIV counseling and testing of tuberculosis patients in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). 48: 190-5. PMID 18520677 DOI: 10.1097/Qai.0B013E3181775926 |
0.779 |
|
| 2008 |
Chaisson RE, Martinson NA. Tuberculosis in Africa--combating an HIV-driven crisis. The New England Journal of Medicine. 358: 1089-92. PMID 18337598 DOI: 10.1056/Nejmp0800809 |
0.525 |
|
| 2008 |
Pemba L, Charalambous S, von Gottberg A, Magadla B, Moloi V, Seabi O, Wasas A, Klugman KP, Chaisson RE, Fielding K, Churchyard GJ, Grant AD. Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa. The Journal of Infection. 56: 171-8. PMID 18262281 DOI: 10.1016/J.Jinf.2007.12.003 |
0.401 |
|
| 2007 |
Rosenthal IM, Zhang M, Williams KN, Peloquin CA, Tyagi S, Vernon AA, Bishai WR, Chaisson RE, Grosset JH, Nuermberger EL. Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model. Plos Medicine. 4: e344. PMID 18092886 DOI: 10.1371/Journal.Pmed.0040344 |
0.371 |
|
| 2007 |
Schluger N, Karunakara U, Lienhardt C, Nyirenda T, Chaisson R. Building clinical trials capacity for tuberculosis drugs in high-burden countries. Plos Medicine. 4: e302. PMID 17988170 DOI: 10.1371/Journal.Pmed.0040302 |
0.528 |
|
| 2007 |
Martinson NA, Karstaedt A, Venter WD, Omar T, King P, Mbengo T, Marais E, McIntyre J, Chaisson RE, Hale M. Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study. Aids (London, England). 21: 2043-50. PMID 17885294 DOI: 10.1097/Qad.0B013E3282Eea47F |
0.539 |
|
| 2007 |
Mello FC, Arias MS, Rosales S, Marsico AG, Pavón A, Alvarado-Gálvez C, Pessôa CL, Pérez M, Andrade MK, Kritski AL, Fonseca LS, Chaisson RE, Kimerling ME, Dorman SE. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. Journal of Clinical Microbiology. 45: 3387-9. PMID 17699652 DOI: 10.1128/Jcm.00580-07 |
0.307 |
|
| 2007 |
Churchyard GJ, Scano F, Grant AD, Chaisson RE. Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. The Journal of Infectious Diseases. 196: S52-62. PMID 17624827 DOI: 10.1086/518662 |
0.532 |
|
| 2007 |
Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. Aids (London, England). 21: 1441-8. PMID 17589190 DOI: 10.1097/Qad.0B013E328216F441 |
0.562 |
|
| 2007 |
Hoffmann CJ, Charalambous S, Thio CL, Martin DJ, Pemba L, Fielding KL, Churchyard GJ, Chaisson RE, Grant AD. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. Aids (London, England). 21: 1301-8. PMID 17545706 DOI: 10.1097/Qad.0B013E32814E6B08 |
0.485 |
|
| 2007 |
Moulton LH, Golub JE, Durovni B, Cavalcante SC, Pacheco AG, Saraceni V, King B, Chaisson RE. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clinical Trials (London, England). 4: 190-9. PMID 17456522 DOI: 10.1177/1740774507076937 |
0.571 |
|
| 2007 |
Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Annals of Internal Medicine. 146: 564-73. PMID 17438315 DOI: 10.7326/0003-4819-146-8-200704170-00007 |
0.457 |
|
| 2007 |
Dorman SE, Chaisson RE. From magic bullets back to the Magic Mountain: The rise of extensively drug-resistant tuberculosis - Commentary Nature Medicine. 13: 295-298. PMID 17342143 DOI: 10.1038/Nm0307-295 |
0.363 |
|
| 2007 |
Arias M, Mello FC, Pavón A, Marsico AG, Alvarado-Gálvez C, Rosales S, Pessôa CL, Pérez M, Andrade MK, Kritski AL, Fonseca LS, Chaisson RE, Kimerling ME, Dorman SE. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 44: 674-80. PMID 17278058 DOI: 10.1086/511639 |
0.349 |
|
| 2007 |
Charalambous S, Grant AD, Day JH, Pemba L, Chaisson RE, Kruger P, Martin D, Wood R, Brink B, Churchyard GJ. Establishing a workplace antiretroviral therapy programme in South Africa. Aids Care. 19: 34-41. PMID 17129856 DOI: 10.1080/09500340600677872 |
0.414 |
|
| 2007 |
Cavalcante SC, Soares ECC, Pacheco AGF, Chaisson RE, Durovni B, Team DE. Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model. International Journal of Tuberculosis and Lung Disease. 11: 544-549. DOI: 10.1007/S11296-006-0033-X |
0.383 |
|
| 2006 |
Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A, Chaisson RE, Maartens G. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. Journal of Acquired Immune Deficiency Syndromes (1999). 43: S127-33. PMID 17133196 DOI: 10.1097/01.Qai.0000248349.25630.3D |
0.432 |
|
| 2006 |
Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. Journal of Acquired Immune Deficiency Syndromes (1999). 43: 78-84. PMID 16878045 DOI: 10.1097/01.Qai.0000225015.43266.46 |
0.44 |
|
| 2006 |
Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle M, Mosher AW, Choudhri S, Daley CL, Munsiff SS, Zhao Z, Vernon A, Chaisson RE. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine. 174: 331-338. PMID 16675781 DOI: 10.1164/Rccm.200603-360Oc |
0.485 |
|
| 2006 |
Kali PBN, Gray GE, Violari A, Chaisson RE, Mcintyre JA, Martinson NA. Combining PMTCT with active case finding for tuberculosis. Journal of Acquired Immune Deficiency Syndromes. 42: 379-381. PMID 16645548 DOI: 10.1097/01.Qai.0000218434.20404.9C |
0.54 |
|
| 2006 |
Dowdy DW, Chaisson RE, Moulton LH, Dorman SE. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. Aids (London, England). 20: 751-62. PMID 16514306 DOI: 10.1097/01.Aids.0000216376.07185.Cc |
0.532 |
|
| 2006 |
Mello FC, Bastos LG, Soares SL, Rezende VM, Conde MB, Chaisson RE, Kritski AL, Ruffino-Netto A, Werneck GL. Predicting smear negative pulmonary tuberculosis with classification trees and logistic regression: a cross-sectional study. Bmc Public Health. 6: 43. PMID 16504086 DOI: 10.1186/1471-2458-6-43 |
0.37 |
|
| 2006 |
Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, Coberly JS, Moore RD, Chaisson RE. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. American Journal of Respiratory and Critical Care Medicine. 173: 922-6. PMID 16474028 DOI: 10.1164/Rccm.200512-1953Oc |
0.509 |
|
| 2006 |
Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. American Journal of Epidemiology. 163: 412-20. PMID 16394200 DOI: 10.1093/Aje/Kwj059 |
0.41 |
|
| 2005 |
Grant AD, Charalambous S, Fielding KL, Day JH, Corbett EL, Chaisson RE, Cock KMD, Hayes RJ, Churchyard GJ. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: A novel randomized incremental recruitment study Jama. 293: 2719-2725. PMID 15941800 DOI: 10.1001/Jama.293.22.2719 |
0.559 |
|
| 2005 |
Wilson D, Nachega JB, Chaisson RE, Maartens G. Diagnostic yield of peripheral lymph node needle-core biopsies in HIV-infected adults with suspected smear-negative tuberculosis International Journal of Tuberculosis and Lung Disease. 9: 220-222. PMID 15732745 |
0.36 |
|
| 2005 |
Nachega JB, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, Karstaedt AS. HIV/AIDS and antiretroviral treatment knowledge, attitudes, beliefs, and practices in HIV-infected adults in Soweto, South Africa Journal of Acquired Immune Deficiency Syndromes. 38: 196-201. PMID 15671805 DOI: 10.1097/00126334-200502010-00011 |
0.46 |
|
| 2005 |
Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatology (Baltimore, Md.). 41: 123-31. PMID 15619237 DOI: 10.1002/Hep.20541 |
0.358 |
|
| 2005 |
Karakousis P, Moore RD, Chaisson RE. Non-tuberculous mycobacteria in HIV-infected patients: geographic, behavioural, and immunological factors – Authors' reply The Lancet Infectious Diseases. 5: 396. DOI: 10.1016/S1473-3099(05)70147-X |
0.463 |
|
| 2004 |
Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, Karstaedt AS. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa Aids Research and Human Retroviruses. 20: 1053-1056. PMID 15585095 DOI: 10.1089/Aid.2004.20.1053 |
0.462 |
|
| 2004 |
Sulkowski MS, Mehta SH, Chaisson RE, Thomas DL, Moore RD. Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir. Aids (London, England). 18: 2277-84. PMID 15577540 DOI: 10.1097/00002030-200411190-00008 |
0.302 |
|
| 2004 |
Day JH, Grant AD, Fielding KL, Morris L, Moloi V, Charalambous S, Puren AJ, Chaisson RE, Cock KMD, Hayes RJ, Churchyard GJ. Does tuberculosis increase HIV load The Journal of Infectious Diseases. 190: 1677-1684. PMID 15478075 DOI: 10.1086/424851 |
0.534 |
|
| 2004 |
Boyd SJ, Thomas-Gosain NF, Umbricht A, Tucker MJ, Leslie JM, Chaisson RE, Preston KL. Gender differences in indices of opioid dependency and medical comorbidity in a population of hospitalized HIV-infected African-Americans. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 13: 281-91. PMID 15370947 DOI: 10.1080/10550490490459960 |
0.34 |
|
| 2004 |
Gordin FM, Cohn DL, Matts JP, Chaisson RE, O'Brien RJ. Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: Is it different than in HIV-uninfected persons? Clinical Infectious Diseases. 39: 561-565. PMID 15356822 DOI: 10.1086/422724 |
0.489 |
|
| 2004 |
Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. The Lancet. Infectious Diseases. 4: 557-65. PMID 15336223 DOI: 10.1016/S1473-3099(04)01130-2 |
0.503 |
|
| 2004 |
Nuermberger EL, Yoshimatsu T, Tyagi S, Williams K, Rosenthal I, O'Brien RJ, Vernon AA, Chaisson RE, Bishai WR, Grosset JH. Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis. American Journal of Respiratory and Critical Care Medicine. 170: 1131-4. PMID 15306535 DOI: 10.1164/Rccm.200407-885Oc |
0.375 |
|
| 2004 |
Moore RD, Keruly JC, Chaisson RE. Differences in HIV disease progression by injecting drug use in HIV-infected persons in care. Journal of Acquired Immune Deficiency Syndromes (1999). 35: 46-51. PMID 14707791 DOI: 10.1097/00126334-200401010-00006 |
0.494 |
|
| 2004 |
Charalambous S, Grant AD, Day JH, Rothwell E, Chaisson RE, Hayes RJ, Churchyard GJ. Feasibility and acceptability of a specialist clinical service for HIV-infected mineworkers in South Africa Aids Care-Psychological and Socio-Medical Aspects of Aids\/Hiv. 16: 47-56. PMID 14660143 DOI: 10.1080/09540120310001633967 |
0.465 |
|
| 2004 |
Nuermberger EL, Yoshimatsu T, Tyagi S, O'Brien RJ, Vernon AN, Chaisson RE, Bishai WR, Grosset JH. Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. American Journal of Respiratory and Critical Care Medicine. 169: 421-6. PMID 14578218 DOI: 10.1164/Rccm.200310-1380Oc |
0.469 |
|
| 2004 |
Wagner KR, Chaisson RE. Pulmonary Complications of HIV Infection Aids and Other Manifestations of Hiv Infection. 407-421. DOI: 10.1016/B978-012764051-8/50018-4 |
0.382 |
|
| 2003 |
Sterling TR, Chaisson RE, Keruly J, Moore RD. Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study. The Journal of Infectious Diseases. 188: 1659-65. PMID 14639536 DOI: 10.1086/379741 |
0.348 |
|
| 2003 |
Chaisson RE. Treatment of chronic infections with rifamycins: Is resistance likely to follow? Antimicrobial Agents and Chemotherapy. 47: 3037-3039. PMID 14506005 DOI: 10.1128/Aac.47.10.3037-3039.2003 |
0.35 |
|
| 2003 |
Churchyard GJ, Fielding K, Charalambous S, Day JH, Corbett EL, Hayes RJ, Chaisson RE, Cock KMD, Samb B, Grant AD. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? Aids. 17: 2063-2070. PMID 14502009 DOI: 10.1097/00002030-200309260-00007 |
0.519 |
|
| 2003 |
Mehta SH, Moore RD, Thomas DL, Chaisson RE, Sulkowski MS. The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 577-84. PMID 12902801 DOI: 10.1097/00126334-200308150-00005 |
0.419 |
|
| 2003 |
Pope DS, Chaisson RE. TB treatment: as simple as DOT? The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 7: 611-5. PMID 12870680 |
0.7 |
|
| 2003 |
Lucas GM, Chaisson RE, Moore RD. Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 321-8. PMID 12843742 DOI: 10.1097/00126334-200307010-00005 |
0.423 |
|
| 2003 |
Nachega J, Coetzee J, Adendorff T, Msandiwa R, Gray GE, McIntyre JA, Chaisson RE. Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. Aids. 17: 1398-1400. PMID 12799565 DOI: 10.1097/00002030-200306130-00018 |
0.553 |
|
| 2003 |
Morris L, Martin DJ, Bredell H, Nyoka SN, Sacks L, Pendle S, Page-Shipp L, Karp CL, Sterling TR, Quinn TC, Chaisson RE. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. The Journal of Infectious Diseases. 187: 1967-71. PMID 12792875 DOI: 10.1086/375346 |
0.412 |
|
| 2003 |
Chaisson RE. Tuberculosis Chemotherapy: Still a Double-edged Sword American Journal of Respiratory and Critical Care Medicine. 167: 1461-1462. PMID 12770849 DOI: 10.1164/Rccm.2303004 |
0.406 |
|
| 2003 |
Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug and Alcohol Dependence. 69: 263-72. PMID 12633912 DOI: 10.1016/S0376-8716(02)00325-3 |
0.376 |
|
| 2003 |
Sterling TR, Chaisson RE, Moore RD. Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicity. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 36: 812-5. PMID 12627368 DOI: 10.1086/367934 |
0.461 |
|
| 2003 |
Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. American Journal of Respiratory and Critical Care Medicine. 167: 603-62. PMID 12588714 DOI: 10.1164/Rccm.167.4.603 |
0.319 |
|
| 2003 |
Nachega JB, Chaisson RE. Tuberculosis drug resistance: A global threat Clinical Infectious Diseases. 36. PMID 12516027 DOI: 10.1086/344657 |
0.376 |
|
| 2003 |
SULKOWSKI M, THOMAS D, MEHTA S, CHAISSON R, MOORE R. 1125 Hepatotoxicity associated with the antiretroviral therapy (ART) containing protease inhibitors (PIS) with or without pharmacokinetic boosting by low-dose ritonavir (RTV) Hepatology. 38: 698-698. DOI: 10.1016/S0270-9139(03)81163-1 |
0.308 |
|
| 2002 |
Park WG, Bishai WR, Chaisson RE, Dorman SE. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. Journal of Clinical Microbiology. 40: 4750-2. PMID 12454186 DOI: 10.1128/Jcm.40.12.4750-4752.2002 |
0.333 |
|
| 2002 |
Benator D, Bhattacharya M, Bozeman L, Burman W, Cantazaro A, Chaisson R, Gordin F, Horsburgh CR, Horton J, Khan A, Lahart C, Metchock B, Pachucki C, Stanton L, Vernon A, et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet. 360: 528-34. PMID 12241657 DOI: 10.1016/S0140-6736(02)09742-8 |
0.465 |
|
| 2002 |
Chaisson RE. TB and HIV: challenges and progress The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 14: 8-9. PMID 12206101 |
0.435 |
|
| 2002 |
Scott CP, Dos Anjos Filho L, De Queiroz Mello FC, Thornton CG, Bishai WR, Fonseca LS, Kritski AL, Chaisson RE, Manabe YC. Comparison of C18-carboxypropylbetaine and standard N-acetyl-L-cysteine-NaOH processing of respiratory specimens for increasing tuberculosis smear sensitivity in Brazil Journal of Clinical Microbiology. 40: 3219-3222. PMID 12202556 DOI: 10.1128/Jcm.40.9.3219-3222.2002 |
0.362 |
|
| 2002 |
Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. Jama. 288: 199-206. PMID 12095384 DOI: 10.1001/Jama.288.2.199 |
0.364 |
|
| 2002 |
Chaisson RE, Armstrong J, Stafford J, Golub J, Bur S. Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners [4] Journal of the American Medical Association. 288: 165-166. PMID 12095379 DOI: 10.1001/Jama.288.2.165 |
0.414 |
|
| 2002 |
Gounder C, De Queiroz Mello FC, Conde MB, Bishai WR, Kritski AL, Chaisson RE, Dorman SE. Field evaluation of a rapid immunochromatographic test for tuberculosis. Journal of Clinical Microbiology. 40: 1989-93. PMID 12037053 DOI: 10.1128/Jcm.40.6.1989-1993.2002 |
0.391 |
|
| 2002 |
Yoshimatsu T, Nuermberger E, Tyagi S, Chaisson R, Bishai W, Grosset J. Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis. Antimicrobial Agents and Chemotherapy. 46: 1875-9. PMID 12019103 DOI: 10.1128/Aac.46.6.1875-1879.2002 |
0.335 |
|
| 2002 |
Bellete B, Coberly J, Barnes GL, Ko C, Chaisson RE, Comstock GW, Bishai WR. Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 1449-56. PMID 12015690 DOI: 10.1086/340397 |
0.41 |
|
| 2002 |
Gillini LA, Cingolani A, Murri R, Luca AD, Giambenedetto SD, Wu AW, Cauda R, Chaisson RE. Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 29: 546-547. PMID 11981374 DOI: 10.1097/00126334-200204150-00018 |
0.488 |
|
| 2002 |
Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. Aids (London, England). 16: 767-74. PMID 11964533 DOI: 10.1097/00002030-200203290-00012 |
0.421 |
|
| 2002 |
Riley ED, Vlahov D, Huettner S, Beilenson P, Bonds M, Chaisson RE. Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore City needle exchange program Journal of Urban Health. 79: 113-127. PMID 11937620 DOI: 10.1093/Jurban/79.1.113 |
0.314 |
|
| 2002 |
Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 752-9. PMID 11850859 DOI: 10.1086/338784 |
0.719 |
|
| 2002 |
Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections Hepatology. 35: 182-189. PMID 11786975 DOI: 10.1053/Jhep.2002.30319 |
0.364 |
|
| 2001 |
Sterling TR, Chaisson RE, Moore RD. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy Aids. 15: 2251-2257. PMID 11698698 DOI: 10.1097/00002030-200111230-00006 |
0.437 |
|
| 2001 |
Keruly JC, Chaisson RE, Moore RD. Increasing incidence of avascular necrosis of the hip in HIV-infected patients [3] Journal of Acquired Immune Deficiency Syndromes. 28: 101-102. PMID 11579286 DOI: 10.1097/00042560-200109010-00017 |
0.462 |
|
| 2001 |
Golub JE, Cronin WA, Obasanjo OO, Coggin W, Moore K, Pope DS, Thompson D, Sterling TR, Harrington S, Bishai WR, Chaisson RE. Transmission of Mycobacterium tuberculosis through casual contact with an infectious case. Archives of Internal Medicine. 161: 2254-8. PMID 11575983 DOI: 10.1001/Archinte.161.18.2254 |
0.734 |
|
| 2001 |
Lucas GM, Chaisson RE, Moore RD. Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz Aids. 15: 1679-1686. PMID 11546943 DOI: 10.1097/00002030-200109070-00011 |
0.44 |
|
| 2001 |
Sterling TR, Dorman SE, Chaisson RE, Ding L, Hackman J, Moore K, Holland SM. Human Immunodeficiency Virus—Seronegative Adults with Extrapulmonary Tuberculosis Have Abnormal Innate Immune Responses Clinical Infectious Diseases. 33: 976-982. PMID 11528568 DOI: 10.1086/322670 |
0.337 |
|
| 2001 |
Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection Journal of Acquired Immune Deficiency Syndromes. 27: 251-259. PMID 11464144 DOI: 10.1097/00126334-200107010-00006 |
0.424 |
|
| 2001 |
Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest. 120: 193-7. PMID 11451837 DOI: 10.1378/Chest.120.1.193 |
0.549 |
|
| 2001 |
Riley ED, Chaisson RE, Robnett TJ, Vertefeuille J, Strathdee SA, Vlahov D. Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors American Journal of Respiratory and Critical Care Medicine. 164: 82-85. PMID 11435243 DOI: 10.1164/Ajrccm.164.1.2101091 |
0.438 |
|
| 2001 |
Poundstone KE, Chaisson RE, Moore RD. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy Aids. 15: 1115-1123. PMID 11416713 DOI: 10.1097/00002030-200106150-00006 |
0.45 |
|
| 2001 |
Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough L, Metha S, Cavalcante S, Moore RD. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. The American Journal of Medicine. 110: 610-5. PMID 11382368 DOI: 10.1016/S0002-9343(01)00695-7 |
0.378 |
|
| 2001 |
Moore RD, Keruly JC, Chaisson RE. Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs Aids. 15: 617-620. PMID 11316999 DOI: 10.1097/00002030-200103300-00011 |
0.374 |
|
| 2001 |
Obasanjo OO, Wu P, Conlon M, Karanfil LV, Pryor P, Moler G, Anhalt G, Chaisson RE, Perl TM. An outbreak of scabies in a teaching hospital: lessons learned. Infection Control and Hospital Epidemiology. 22: 13-18. PMID 11198016 DOI: 10.1086/501818 |
0.354 |
|
| 2000 |
Chaisson RE. New developments in the treatment of latent tuberculosis International Journal of Tuberculosis and Lung Disease. 4. PMID 11144550 |
0.387 |
|
| 2000 |
Sullivan JH, Moore RD, Keruly JC, Chaisson RE. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection American Journal of Respiratory and Critical Care Medicine. 162: 64-67. PMID 10903221 DOI: 10.1164/Ajrccm.162.1.9904101 |
0.442 |
|
| 2000 |
Gordin F, Chaisson RE, Matts JP, Miller C, Garcia MdL, Hafner R, Valdespino JL, Coberly J, Schechter M, Klukowicz AJ, Barry MA, O'Brien RJ. Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected Persons: An International Randomized Trial Jama. 283: 1445-1450. PMID 10732934 DOI: 10.1001/Jama.283.11.1445 |
0.558 |
|
| 2000 |
Rao SN, Mookerjee AL, Obasanjo OO, Chaisson RE. Errors in the treatment of tuberculosis in Baltimore Chest. 117: 734-737. PMID 10712999 DOI: 10.1378/Chest.117.3.734 |
0.487 |
|
| 2000 |
Sterling TR, Pope DS, Bishai WR, Harrington S, Gershon RR, Chaisson RE. Transmission of Mycobacterium tuberculosis from a cadaver to an embalmer. The New England Journal of Medicine. 342: 246-8. PMID 10648766 DOI: 10.1056/Nejm200001273420404 |
0.72 |
|
| 2000 |
Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection Journal of the American Medical Association. 283: 74-80. PMID 10632283 DOI: 10.1001/Jama.283.1.74 |
0.377 |
|
| 1999 |
Chaisson RE. Update on treatment and prevention guidelines for HIV-related tuberculosis The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 11. PMID 11367371 |
0.435 |
|
| 1999 |
Chaisson RE. HIV becomes world's leading infectious cause of death The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 11: 1. PMID 11366920 |
0.328 |
|
| 1999 |
Bishai WR, Chaisson RE. Opportunistic infections: down but not out The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 11. PMID 11366247 |
0.367 |
|
| 1999 |
Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination antiretroviral therapy Aids. 13: 1933-1942. PMID 10513653 DOI: 10.1097/00002030-199910010-00017 |
0.446 |
|
| 1999 |
Sterling TR, Alwood K, Gachuhi R, Coggin W, Blazes D, Bishai WR, Chaisson RE. Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons. Aids (London, England). 13: 1899-904. PMID 10513648 DOI: 10.1097/00002030-199910010-00012 |
0.552 |
|
| 1999 |
Miyazaki E, Chaisson RE, Bishai WR. Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis Antimicrobial Agents and Chemotherapy. 43: 2126-2130. PMID 10471552 DOI: 10.1128/Aac.43.9.2126 |
0.43 |
|
| 1999 |
Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions Annals of Internal Medicine. 131: 81-87. PMID 10419445 DOI: 10.7326/0003-4819-131-2-199907200-00002 |
0.443 |
|
| 1999 |
Corbett EL, Blumberg L, Churchyard GJ, Moloi N, Mallory K, Clayton T, Williams BG, Chaisson RE, Hayes RJ, De Cock KM. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. American Journal of Respiratory and Critical Care Medicine. 160: 15-21. PMID 10390374 DOI: 10.1164/Ajrccm.160.1.9812080 |
0.398 |
|
| 1999 |
De Cock KM, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection International Journal of Tuberculosis and Lung Disease. 3: 457-465. PMID 10383056 |
0.483 |
|
| 1999 |
Gebo KA, Chaisson RE, Folkemer JG, Bartlett JG, Moore RD. Costs of HIV medical care in the era of highly active antiretroviral therapy Aids. 13: 963-969. PMID 10371178 DOI: 10.1097/00002030-199905280-00013 |
0.387 |
|
| 1999 |
Oursler KAK, Moore RD, Chaisson RE. Risk factors for cryptococcal meningitis in HIV-infected patients Aids Research and Human Retroviruses. 15: 625-631. PMID 10331441 DOI: 10.1089/088922299310926 |
0.454 |
|
| 1999 |
Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Medicine. 5: 512-7. PMID 10229227 DOI: 10.1038/8394 |
0.451 |
|
| 1999 |
Gallant JE, Chaisson RE, Keruly JC, Moore RD. Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients Aids. 13: 225-229. PMID 10202828 DOI: 10.1097/00002030-199902040-00010 |
0.423 |
|
| 1999 |
Kimura M, Converse PJ, Astemborski J, Rothel JS, Vlahov D, Comstock GW, Graham NM, Chaisson RE, Bishai WR. Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. The Journal of Infectious Diseases. 179: 1297-300. PMID 10191241 DOI: 10.1086/314707 |
0.418 |
|
| 1999 |
Sterling TR, Brehm WT, Moore RD, Chaisson RE. Tuberculosis vaccination versus isoniazid preventive therapy: A decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world International Journal of Tuberculosis and Lung Disease. 3: 248-254. PMID 10094327 |
0.339 |
|
| 1999 |
Moore RD, Cheever L, Keruly JC, Chaisson RE. Lack of sex difference in CD4 to HIV-1 RNA viral load ratio Lancet. 353: 463-464. PMID 9989720 DOI: 10.1016/S0140-6736(98)05379-3 |
0.349 |
|
| 1999 |
Miyazaki E, Miyazaki M, Chen JM, Chaisson RE, Bishai WR. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis Antimicrobial Agents and Chemotherapy. 43: 85-89. PMID 9869570 DOI: 10.1128/Aac.43.1.85 |
0.355 |
|
| 1999 |
Sulkowski MS, Chaisson RE, Karp CL, Moore RD, Margolick JB, Quinn TC. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. The Journal of Infectious Diseases. 178: 1642-8. PMID 9815216 DOI: 10.1086/314491 |
0.415 |
|
| 1999 |
Miyazaki E, Chaisson RE, Bishai WR. Analysis of Rifapentine for Preventive Therapy in the Cornell Mouse Model of Latent Tuberculosis Antimicrobial Agents and Chemotherapy. 43: 2126-2130. DOI: 10.1128/AAC.43.9.2126 |
0.318 |
|
| 1998 |
Chaisson RE. Short course preventive therapy for tuberculosis is successful in HIV-infected patients The Hopkins Hiv Report : a Bimonthly Newsletter For Healthcare Providers / Johns Hopkins University Aids Service. 10: 2-3. PMID 11365493 |
0.503 |
|
| 1998 |
Bishai WR, Graham NM, Harrington S, Pope DS, Hooper N, Astemborski J, Sheely L, Vlahov D, Glass GE, Chaisson RE. Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. Jama. 280: 1679-84. PMID 9831999 DOI: 10.1001/Jama.280.19.1679 |
0.724 |
|
| 1998 |
Gallant JE, Chaisson RE, Moore RD. The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications Chest. 114: 1258-1263. PMID 9823998 DOI: 10.1378/Chest.114.5.1258 |
0.353 |
|
| 1998 |
Morris L, Martin DJ, Quinn TC, Chaisson RE. The importance of doing HIV research in developing countries Nature Medicine. 4: 1228-1229. PMID 9809535 DOI: 10.1038/3206 |
0.417 |
|
| 1998 |
Manabe YC, Clark DP, Moore RD, Lumadue JA, Dahlman HR, Belitsos PC, Chaisson RE, Sears CL. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 27: 536-42. PMID 9770154 DOI: 10.1086/514701 |
0.383 |
|
| 1998 |
Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 19: 29-33. PMID 9732065 DOI: 10.1097/00042560-199809010-00004 |
0.44 |
|
| 1998 |
Halsey NA, Coberly J, Chaisson R. Prevention of tuberculosis in HIV-1 [9] Lancet. 352: 742. PMID 9729026 DOI: 10.1016/S0140-6736(05)60866-5 |
0.358 |
|
| 1998 |
Sterling TR, Moore RD, Graham NM, Astemborski J, Vlahov D, Chaisson RE. Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease. Aids (London, England). 12: 1451-7. PMID 9727565 DOI: 10.1097/00002030-199812000-00006 |
0.44 |
|
| 1998 |
Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 18: 117-125. PMID 9637576 DOI: 10.1097/00042560-199806010-00003 |
0.401 |
|
| 1998 |
Halsey NA, Coberly JS, Desormeaux J, Losikoff P, Atkinson J, Moulton LH, Contave M, Johnson M, Davis H, Geiter L, Johnson E, Huebner R, Boulos R, Chaisson RE. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection Lancet. 351: 786-792. PMID 9519950 DOI: 10.1016/S0140-6736(97)06532-X |
0.568 |
|
| 1998 |
Chaisson RE, Gallant JE, Keruly JC, Moore RD. Impact of opportunistic disease on survival in patients with HIV infection Aids. 12: 29-33. PMID 9456252 DOI: 10.1097/00002030-199801000-00004 |
0.371 |
|
| 1997 |
Erbelding EJ, Chaisson RE, Gallant JE, Moore RD. Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease Antiviral Therapy. 2: 71-77. PMID 11322278 |
0.352 |
|
| 1997 |
Chaisson RE, Moore RD. Prevention of opportunistic infections in the era of improved antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 16. PMID 9389311 DOI: 10.1097/00042560-199701001-00003 |
0.453 |
|
| 1997 |
Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (New York, N.Y.). 278: 1295-300. PMID 9360927 DOI: 10.1126/Science.278.5341.1295 |
0.416 |
|
| 1997 |
Michele TM, Cronin WA, Graham NM, Dwyer DM, Pope DS, Harrington S, Chaisson RE, Bishai WR. Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprinting. Jama. 278: 1093-5. PMID 9315769 |
0.714 |
|
| 1997 |
Gielen AC, Faden RR, Kass NE, O'Campo P, Chaisson R, Watkinson L. Evaluation of an HIV/AIDS education program in an urban prenatal clinic. Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health. 7: 269-78. PMID 9283282 DOI: 10.1016/S1049-3867(97)00029-7 |
0.369 |
|
| 1997 |
Styrt BA, Chaisson RE, Moore RD. Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients Aids. 11: 1243-1248. PMID 9256942 DOI: 10.1097/00002030-199710000-00007 |
0.431 |
|
| 1997 |
Chaisson RE, Keiser P, Pierce M, Fessel WJ, Ruskin J, Lahart C, Benson CA, Meek K, Siepman N, Craft JC. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection. Aids (London, England). 11: 311-7. PMID 9147422 DOI: 10.1097/00002030-199703110-00008 |
0.473 |
|
| 1997 |
Moore RD, Chaisson RE. Costs to medicaid of advancing immunosuppression in an urban HIV- infected patient population in Maryland Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 14: 223-231. PMID 9117454 DOI: 10.1097/00042560-199703010-00005 |
0.384 |
|
| 1997 |
Bishai WR, Chaisson RE. Short-course chemoprophylaxis for tuberculosis Clinics in Chest Medicine. 18: 115-122. PMID 9098615 DOI: 10.1016/S0272-5231(05)70360-9 |
0.454 |
|
| 1997 |
Moore RD, Keruly JC, Chaisson RE. The effectiveness of combination antiretroviral therapy in clinical practice Clinical Infectious Diseases. 25: 395. |
0.336 |
|
| 1997 |
Sterling TR, Moore RD, Gibson J, Astemborski J, Vlahov D, Chaisson RE. The impact of M. tuberculosis infection on subsequent disseminated MAC disease in KV-infected persons Clinical Infectious Diseases. 25: 447. |
0.44 |
|
| 1996 |
Chaisson RE, Clermont HC, Holt EA, Cantave M, Johnson MP, Atkinson J, Davis H, Boulos R, Quinn TC, Halsey NA, Desormeaux J, Joseph H, Buteau J, LaMothe F, Elie R, et al. Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection American Journal of Respiratory and Critical Care Medicine. 154: 1034-1038. PMID 8887603 DOI: 10.1164/Ajrccm.154.4.8887603 |
0.55 |
|
| 1996 |
Chaisson RE. Potential role of rifabutin in prophylaxis for tuberculosis and infections due to multiple opportunistic pathogens Clinical Infectious Diseases. 22. PMID 8785259 DOI: 10.1093/Clinids/22.Supplement_1.S61 |
0.453 |
|
| 1996 |
Moore RD, Fortgang I, Keruly J, Chaisson RE. Adverse events from drug therapy for human immunodeficiency virus disease American Journal of Medicine. 101: 34-40. PMID 8686712 DOI: 10.1016/S0002-9343(96)00077-0 |
0.358 |
|
| 1996 |
Moore RD, Keruly JC, Chaisson RE. Duration of the survival benefit of zidovudine therapy in HIV infection Archives of Internal Medicine. 156: 1073-1077. PMID 8638994 DOI: 10.1001/Archinte.1996.00040041073005 |
0.467 |
|
| 1996 |
Janis EM, Allen DW, Glesby MJ, Carey LA, Mundy LM, Gopalan R, Chaisson RE. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff. The American Journal of Medicine. 100: 186-92. PMID 8629653 DOI: 10.1016/S0002-9343(97)89457-0 |
0.517 |
|
| 1996 |
Bishai WR, Graham NM, Harrington S, Page C, Moore-Rice K, Hooper N, Chaisson RE. Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis. The New England Journal of Medicine. 334: 1573-6. PMID 8628338 DOI: 10.1056/Nejm199606133342404 |
0.503 |
|
| 1996 |
Ewig S, Gallani JE, Bartlett JG, Chaisson RE. The effect of prophylaxis on the outcome of HIV-associated Pneumocystis carinii pneumonia [7] Chest. 109: 586-587. PMID 8620753 |
0.316 |
|
| 1996 |
Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort Annals of Internal Medicine. 124: 633-642. PMID 8607591 DOI: 10.7326/0003-4819-124-7-199604010-00003 |
0.454 |
|
| 1996 |
Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD. Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 11: 455-459. PMID 8605590 DOI: 10.1097/00042560-199604150-00005 |
0.374 |
|
| 1996 |
Gebo KA, Moore RD, Keruly JC, Chaisson RE. Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients Journal of Infectious Diseases. 173: 857-862. PMID 8603963 DOI: 10.1093/Infdis/173.4.857 |
0.355 |
|
| 1996 |
Maenza JR, Keruly JC, Moore RD, Chaisson RE, Merz WG, Gallant JE. Risk Factors for Fluconazole-Resistant Candidiasis in Human Immunodeficiency Virus-Infected Patients The Journal of Infectious Diseases. 173: 219-225. PMID 8537662 DOI: 10.1093/Infdis/173.1.219 |
0.359 |
|
| 1996 |
Maenza JR, Chaisson RE. HIV disease and its treatment: Current status and future prospects International Review of Psychiatry. 8: 167-175. DOI: 10.3109/09540269609046301 |
0.497 |
|
| 1996 |
Gallant JE, Bartlett JG, Chaisson RE. Communications to the EditorThe Effect of Prophylaxis on the Outcome of HIV-Associated Pneumocystis carinii Pneumonia Chest. 109. DOI: 10.1378/Chest.109.2.587 |
0.397 |
|
| 1996 |
Gallant JE, Abrams JE, McAvinue SM, Quinn TC, Chaisson RE. Previously unrecognized HIV infection among hospitalized patients Infectious Diseases in Clinical Practice. 5: 380-386. DOI: 10.1097/00019048-199608000-00008 |
0.397 |
|
| 1996 |
Moore RD, Chaisson RE. Neutropenia and latrogenic Neutrophil Dysfunction in Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome-Reply Jama Internal Medicine. 156: 1475-1476. DOI: 10.1001/Archinte.1996.00440120141018 |
0.4 |
|
| 1995 |
Chaisson RE. Mycobacterium avium complex and HIV Journal of the International Association of Physicians in Aids Care. 1: 10-15. PMID 11362745 |
0.387 |
|
| 1995 |
Moore RD, Chaisson RE. Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS Aids. 9: 1337-1342. PMID 8605053 DOI: 10.1097/00002030-199512000-00006 |
0.318 |
|
| 1995 |
Glesby MJ, Moore RD, Chaisson RE. Clinical Spectrum of Herpes Zoster in Adults Infected with Human Immunodeficiency Virus Clinical Infectious Diseases. 21: 370-375. PMID 8562746 DOI: 10.1093/Clinids/21.2.370 |
0.418 |
|
| 1995 |
Lanier D, Schram N, Cooper E, Freedberg KA, Mayer K, Blinkhorn R, Ellner J, Angulo F, Berkelman R, Breiman R, Bryan R, Buehler J, Caldwell B, Castro K, Childs JE, ... ... Chaisson R, et al. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Disease-specific recommendations Clinical Infectious Diseases. 21. PMID 8547510 DOI: 10.1093/Clinids/21.Supplement_1.S32 |
0.341 |
|
| 1995 |
Chaisson RE. Mycobacterial infections and HIV Kekkaku. 70: 313-320. PMID 7760541 DOI: 10.1097/00001432-199304000-00016 |
0.469 |
|
| 1995 |
Gallant JE, McAvinue SM, Moore RD, Bartlett JG, Stanton DL, Chaisson RE. The Impact of Prophylaxis on Outcome and Resource Utilization in Pneumocystis carinii Pneumonia Chest. 107: 1018-1023. PMID 7705108 DOI: 10.1378/Chest.107.4.1018 |
0.448 |
|
| 1995 |
Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis Journal of the American Medical Association. 274: 945-951. PMID 7674524 DOI: 10.1001/Jama.1995.03530120037038 |
0.479 |
|
| 1995 |
Fortgang IS, Peter AB, Belitsos PC, Chaisson RE, Moore RD. Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy American Journal of Gastroenterology. 90: 1433-1436. PMID 7661164 |
0.376 |
|
| 1995 |
Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease New England Journal of Medicine. 333: 751-756. PMID 7643881 DOI: 10.1056/Nejm199509213331202 |
0.415 |
|
| 1995 |
Gallant JE, Moore RD, Keruly J, Richman DD, Chaisson RE. Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group. The Journal of Infectious Diseases. 172: 346-52. PMID 7622876 DOI: 10.1093/Infdis/172.2.346 |
0.359 |
|
| 1995 |
Moore RD, Keruly JC, Chaisson RE. Neutropenia and Bacterial Infection in Acquired Immunodeficiency Syndrome Archives of Internal Medicine. 155: 1965-1970. PMID 7575050 DOI: 10.1001/Archinte.1995.00430180067008 |
0.429 |
|
| 1995 |
Chaisson RE. AIDS and mycobacterial infections Infections in Medicine. 12: 48-57. |
0.468 |
|
| 1995 |
Barditch-Crovo P, Chaisson RE. Adverse reactions to therapy for HIV infection Emergency Medicine Clinics of North America. 13: 133-146. |
0.328 |
|
| 1994 |
Small PM, Hopewell PC, Schecter GF, Chaisson RE, Goodman PC. Evolution of chest radiographs in treated patients with pulmonary tuberculosis and HIV infection Journal of Thoracic Imaging. 9: 74-77. PMID 8207783 DOI: 10.1097/00005382-199421000-00003 |
0.559 |
|
| 1994 |
Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection Annals of Internal Medicine. 120: 932-944. PMID 8172439 DOI: 10.7326/0003-4819-120-11-199406010-00006 |
0.487 |
|
| 1994 |
Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine Archives of Internal Medicine. 154: 566-572. PMID 8122950 DOI: 10.1001/Archinte.1994.00420050132012 |
0.32 |
|
| 1994 |
Moore RD, Stanton D, Gopalan R, Chaisson RE. Racial differences in the use of drug therapy for HIV disease in an urban community. The New England Journal of Medicine. 330: 763-8. PMID 8107743 DOI: 10.1056/Nejm199403173301107 |
0.446 |
|
| 1994 |
Simon PA, Sorvillo FJ, Lapin RK, Moore RD, Chaisson RE. Racial differences in the use of drug therapy for HIV disease [4] New England Journal of Medicine. 331: 333-334. PMID 8022459 DOI: 10.1056/NEJM199408043310517 |
0.312 |
|
| 1994 |
Alwood K, Keruly J, Moore-Rice K, Stanton DL, Chaulk CP, Chaisson RE. Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients Aids. 8: 1103-1108. PMID 7986406 DOI: 10.1097/00002030-199408000-00010 |
0.558 |
|
| 1994 |
Chaisson RE, Benson CA, Dube MP, Heifets LB, Korvick JA, Elkin S, Smith T, Craft JC, Sattler FR. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: A randomized, double-blind, dose-ranging study in patients with AIDS Annals of Internal Medicine. 121: 905-911. PMID 7978715 DOI: 10.7326/0003-4819-121-12-199412150-00001 |
0.368 |
|
| 1994 |
Chaisson RE. NONTUBERCULOUS MYCOBACTERIAL INFECTIONS IN HIV DISEASE Aids. 8: S17. DOI: 10.1097/00002030-199411004-00064 |
0.465 |
|
| 1994 |
Chaulk CP, Chaisson RE, Lewis JN, Rizzo RT. Treating Multidrug-Resistant Tuberculosis: Compliance and Side Effects Jama: the Journal of the American Medical Association. 271: 103-104. DOI: 10.1001/Jama.1994.03510260027017 |
0.437 |
|
| 1994 |
Chaisson RE, Goedert JJ. Epidemiology of HIV infection among hemophiliacs and importance of CD4+ cells as surrogate markers Aids Patient Care. 8. |
0.309 |
|
| 1994 |
Gallant JE, Alwood K, Chaisson RE. Osteomyelitis due to mycobacterium kansasii and mycobacterium avium complex in an HIV-infected patient Infectious Diseases in Clinical Practice. 3: 297-299. |
0.398 |
|
| 1993 |
Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection The American Journal of Cardiology. 71: 955-958. PMID 8465788 DOI: 10.1016/0002-9149(93)90913-W |
0.434 |
|
| 1993 |
Graham NMH, Chaisson RE. Tuberculosis and HIV infection: Epidemiology, pathogenesis, and clinical aspects Annals of Allergy. 71: 421-433. PMID 8250347 |
0.455 |
|
| 1993 |
Glesby MJ, Moore RD, Chaisson RE. Herpes Zoster in Patients with Advanced Human Immunodeficiency Virus Infection Treated with Zidovudine The Journal of Infectious Diseases. 168: 1264-1268. PMID 8228361 DOI: 10.1093/Infdis/168.5.1264 |
0.415 |
|
| 1993 |
Johnson MP, Chaisson RE. Tuberculosis and HIV disease Aids Clinical Review. 73-93. PMID 8217905 |
0.426 |
|
| 1993 |
Nightingale SD, Cameron DW, Gordin FM, Sullam PM, Cohn DL, Chaisson RE, Eron LJ, Sparti PD, Bihari B, Kaufman DL, Stern JJ, Pearce DD, Weinberg WG, Lamarca A, Siegal FP. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in aids New England Journal of Medicine. 329: 828-833. PMID 8179648 DOI: 10.1056/Nejm199309163291202 |
0.367 |
|
| 1993 |
Chaisson RE, Stanton DL, Gallant JE, Rucker S, Bartlett JG, Moore RD. Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting. Aids. 7: 857-862. PMID 8103343 DOI: 10.1097/00002030-199306000-00015 |
0.411 |
|
| 1993 |
Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. The American Review of Respiratory Disease. 146: 285-9. PMID 1362634 DOI: 10.1164/Ajrccm/146.2.285 |
0.374 |
|
| 1993 |
Ward BJ, Humphrey JH, Clement L, Chaisson RE. Vitamin A status in HIV infection Nutrition Research. 13: 157-166. DOI: 10.1016/S0271-5317(05)80437-3 |
0.334 |
|
| 1992 |
Johnson MP, Coberly JS, Camile Clermont H, Chaisson RE, Davis HL, Losikoff P, Ruff AJ, Boulos R, Halsey NA. Tuberculin skin test reactivity among adults infected with human immunodeficiency virus Journal of Infectious Diseases. 166: 194-208. PMID 1607696 DOI: 10.1093/Infdis/166.1.194 |
0.452 |
|
| 1992 |
Samuels JF, Vlahov D, Anthony JC, Chaisson RE. Measurement of HIV risk behaviors among intravenous drug users. British Journal of Addiction. 87: 417-28. PMID 1559040 DOI: 10.1111/J.1360-0443.1992.Tb01942.X |
0.357 |
|
| 1992 |
Gallant JE, Mueller PS, McArthur JC, Chaisson RE. Intramedullary tuberculoma in a patient with HIV infection [10] Aids. 6: 889-891. PMID 1418794 |
0.374 |
|
| 1992 |
Chaisson RE, Keruly J, Richman DD, Moore RD. Pneumocystis Prophylaxis and Survival in Patients With Advanced Human Immunodeficiency Virus Infection Treated With Zidovudine Archives of Internal Medicine. 152: 2009-2013. PMID 1417373 DOI: 10.1001/Archinte.1992.00400220041007 |
0.422 |
|
| 1992 |
Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. The Journal of Infectious Diseases. 166: 1223-7. PMID 1358986 DOI: 10.1093/Infdis/166.6.1223 |
0.322 |
|
| 1992 |
Gallant JE, Somani J, Chaisson RE, Stanton D, Smith M, Quinn TC. Diagnostic accuracy of three clinical case definitions for advanced HIV disease. Aids (London, England). 6: 295-9. PMID 1348946 DOI: 10.1097/00002030-199203000-00006 |
0.405 |
|
| 1992 |
Moore RD, Keruly J, Richman DD, Creagh-Kirk T, Chaisson RE. Natural history of advanced HIV disease in patients treated with zidovudane Aids. 6: 671-678. DOI: 10.1097/00002030-199207000-00009 |
0.367 |
|
| 1991 |
Chaisson RE, McAvinue S. Control of tuberculosis during aerosol therapy administration Respiratory Care. 36: 1017-1025. PMID 10145536 |
0.342 |
|
| 1991 |
Moore RD, Hidalgo J, Sugland BW, Chaisson RE. Zidovudine and the natural history of the acquired immunodeficiency syndrome New England Journal of Medicine. 324: 1412-1416. PMID 2020297 DOI: 10.1056/Nejm199105163242006 |
0.327 |
|
| 1991 |
Moore RD, Kessler H, Richman DD, Flexner C, Chaisson RE. Non-Hodgkin’s Lymphoma in Patients With Advanced HIV Infection Treated With Zidovudine Jama: the Journal of the American Medical Association. 265: 2208-2211. PMID 2013953 DOI: 10.1001/Jama.1991.03460170062034 |
0.445 |
|
| 1991 |
Chaisson RE, Fuchs E, Stanton DL, Quinn TC, Hendricksen C, Bartlett JG, Farzadegan H. Racial heterogeneity of HIV antigenemia in people with HIV infection. Aids. 5: 177-180. PMID 1903261 DOI: 10.1097/00002030-199102000-00007 |
0.46 |
|
| 1991 |
Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. The New England Journal of Medicine. 324: 289-294. PMID 1898769 DOI: 10.1056/Nejm199101313240503 |
0.512 |
|
| 1991 |
Flexner C, Barditch-Crovo PA, Kornhauser DM, Farzadegan H, Nerhood LJ, Chaisson RE, Bell KM, Lorentsen KJ, Hendrix CW, Petty BG, Lietman PS. Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection Antimicrobial Agents and Chemotherapy. 35: 2544-2550. PMID 1810188 DOI: 10.1128/Aac.35.12.2544 |
0.453 |
|
| 1991 |
Levine B, Chaisson RE. Mycobacterium kansasii: A cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection Annals of Internal Medicine. 114: 861-868. PMID 1673053 DOI: 10.7326/0003-4819-114-10-861 |
0.464 |
|
| 1991 |
Barbacci M, Chaisson RE, Repke JT. Routine prenatal screening for HIV infection The Lancet. 337: 709-711. PMID 1672184 DOI: 10.1016/0140-6736(91)90286-X |
0.429 |
|
| 1991 |
Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. Bmj. 302: 73-78. PMID 1671651 DOI: 10.1136/Bmj.302.6768.73 |
0.361 |
|
| 1991 |
Hendrix CW, Volberding PA, Chaisson RE. HIV Antigen Variability in ARC/AIDS Jaids Journal of Acquired Immune Deficiency Syndromes. 4: 847???850. DOI: 10.1097/00126334-199109000-00003 |
0.443 |
|
| 1990 |
Chaisson RE. Prevention of opportunistic infections in patients with HIV Maryland Medical Journal. 39: 156-160. PMID 2406531 |
0.378 |
|
| 1990 |
Chaisson RE. Living With AIDS Jama: the Journal of the American Medical Association. 263: 434-436. PMID 2294309 DOI: 10.1001/Jama.1990.03440030121034 |
0.359 |
|
| 1990 |
Theuer CP, Hopewell PC, Elias D, Schecter GF, Rutherford GW, Chaisson RE. Human immunodeficiency virus infection in tuberculosis patients. The Journal of Infectious Diseases. 162: 8-12. PMID 1972384 DOI: 10.1093/Infdis/162.1.8 |
0.544 |
|
| 1990 |
Chaisson RE, Hopewell PC. Survival after Active Tuberculosis in Patients with HIV Infection: Reply The American Review of Respiratory Disease. 142: 259-259. DOI: 10.1164/Ajrccm/142.1.259 |
0.53 |
|
| 1990 |
Chaisson RE, Hopewell PC. Survival after active tuberculosis in patients with HIV infection (I: Reply) American Review of Respiratory Disease. 142: 259. |
0.438 |
|
| 1989 |
Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine Use and HIV Infection in Intravenous Drug Users in San Francisco Jama: the Journal of the American Medical Association. 261: 561-565. PMID 2909798 DOI: 10.1001/Jama.1989.03420040099027 |
0.35 |
|
| 1989 |
Chaisson RE. Tuberculosis and HIV infection - New opportunities for an old pathogen Western Journal of Medicine. 150: 687-689. PMID 2750153 |
0.426 |
|
| 1989 |
Chaisson RE, Slutkin G. Tuberculosis and Human Immunodeficiency Virus Infection Journal of Infectious Diseases. 159: 96-100. PMID 2642524 DOI: 10.1093/Infdis/159.1.96 |
0.454 |
|
| 1989 |
Jacobson MA, Abrams DI, Volberding PA, Bacchetti P, Wilber J, Chaisson RE, Crowe S, Howard W, Moss A. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. The Journal of Infectious Diseases. 159: 1029-36. PMID 2566637 DOI: 10.1093/Infdis/159.6.1029 |
0.357 |
|
| 1988 |
Rosenthal PJ, Chaisson RE, Hadley WK, Leech JH. Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome The American Journal of Medicine. 84: 307-309. PMID 3407656 DOI: 10.1016/0002-9343(88)90430-5 |
0.344 |
|
| 1988 |
Osmond D, Bacchetti P, Chaisson RE, Kelly T, Stempel R, Carlson J, Moss AR. Time of exposure and risk of HIV infection in homosexual partners of men with AIDS American Journal of Public Health. 78: 944-948. PMID 3389432 DOI: 10.2105/Ajph.78.8.944 |
0.383 |
|
| 1988 |
Moss AR, Bacchetti P, Osmond D, Krampf W, Chaisson RE, Stites D, Wilber J, Allain J, Carlson J. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Bmj. 296: 745-750. PMID 3126959 DOI: 10.1136/Bmj.296.6624.745 |
0.394 |
|
| 1988 |
Chaisson RE. Effect of Zidovudine on Serum Human Immunodeficiency Virus Core Antigen Levels Archives of Internal Medicine. 148: 2151. DOI: 10.1001/Archinte.1988.00380100045010 |
0.424 |
|
| 1987 |
Celum CL, Chaisson RE, Rutherford GW, Barnhart JL, Echenberg DE. Incidence of salmonellosis in patients with aids Journal of Infectious Diseases. 156: 998-1002. PMID 3680999 DOI: 10.1093/Infdis/156.6.998 |
0.318 |
|
| 1987 |
Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. The American Review of Respiratory Disease. 136: 570-574. PMID 3631730 DOI: 10.1164/Ajrccm/136.3.570 |
0.512 |
|
| 1987 |
Chaisson RE, Hopewell PC. Empiric Diagnosis of Pneumocystis Pneumonia Jama: the Journal of the American Medical Association. 258: 3385. PMID 3500330 DOI: 10.1001/Jama.1987.03400230045016 |
0.329 |
|
| 1987 |
Osmond D, Chaisson R, Moss A, Bacchetti P, Krampf W. Lymphadenopathy in asymptomatic patients seropositive for HIV. The New England Journal of Medicine. 317: 246-246. PMID 3474522 DOI: 10.1056/Nejm198707233170413 |
0.461 |
|
| 1987 |
Chaisson RE, Moss AR, Onishi R, Osmond D, Carlson JR. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco American Journal of Public Health. 77: 169-172. PMID 3467596 DOI: 10.2105/Ajph.77.2.169 |
0.405 |
|
| 1987 |
Chaisson RE, Osmond D, Moss A, Feldman H, Bernacki P. Hiv, Bleach, And Needle Sharing The Lancet. 329: 1430. PMID 2884515 DOI: 10.1016/S0140-6736(87)90615-5 |
0.437 |
|
| 1986 |
Chaisson RE, Allain JP, Leuther M, Volberding PA. Significant changes in HIV antigen level in the serum of patients treated with azidothymidine New England Journal of Medicine. 315: 1610-1611. PMID 3466034 DOI: 10.1056/Nejm198612183152511 |
0.404 |
|
| Show low-probability matches. |